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ABSTRACT OF DISSERTATION 
 
 
 
 
Characterization of Epitheliogenesis Imperfecta in Equus caballus 
 
 
Epitheliogenesis Imperfecta (EI) is a mechanobullous disease that occurs in 
newborn American Saddlebred and Belgian Draft foals. Necropsy evaluations of two 
American Saddlebred foals revealed broad skin lesions, dental abnormalities and oral 
mucosa lesions. Construction of a partial pedigree showing occurrences of EI in American 
Saddlebred horses was consistent with a recessive pattern of inheritance. An allelic 
frequency of 0.04 was estimated for the EI gene. 
The pathological signs of EI were similar to a disease in humans known as Herlitz 
Junctional Epidermolysis Bullosa (HJEB). HJEB is caused by a defect in one of the three 
subunits of the laminin 5 protein (LAM α3, LAM β3 and LAM γ2), which leads to a 
separation of the epidermis from the dermis. 
Transmission electron microscopy revealed a separation within the lamina lucida at 
the sites of epidermal/dermal splits in the skin of EI affected foals. This indicated that a 
defect in the laminin 5 protein was responsible for EI. 
Linkage disequilibrium (LD) between microsatellite markers and the EI disease 
locus was tested for in the American Saddlebred and Belgian Draft breeds. Genotyping of 
  
microsatellite alleles was used to determine fit to Hardy-Weinberg equilibrium for control 
and EI populations for both breeds using Chi square analysis. Two microsatellite loci 
(ASB14 and AHT3) were not in Hardy-Weinberg equilibrium in EI affected American 
Saddlebred horses. This suggested that the EI disease locus was located on ECA 8, the 
putative location of LAM α3. No evidence of LD between any of the tested microsatellite 
loci and the EI locus was observed in the Belgian Draft samples. 
A cDNA library was built from Thoroughbred horse skin to serve as a resource for 
sequencing equine skin gene transcripts. 313 ESTs were sequenced, of which 207 were 
putatively identified (66%) by database search.  
Examination of the pathology and ultrastructure of EI affected foals and comparison 
with HJEB indicated that laminin 5 was the responsible defective protein. The LD analysis 
suggested that LAM α3 was the EI disease locus in American Saddlebred horses.  
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1Chapter One
Introduction and Literature Review
“There is no real difference between structure and function; they are the two sides
of the same coin. If structure does not tell us anything about function it means we
have not looked at it correctly” (Szent-Györgyi, 1951)
One of the challenges of modern veterinary science is to integrate the latest techniques of
molecular biology with the classical methods of histology and morphology study. These classical
approaches to biology provide an excellent basis for identifying structural defects and candidate
genes for study.
The Disease Condition Epitheliogenesis Imperfecta
The pathological entity, which came to be known as Epitheliogenesis Imperfecta, was
first described in horses in Germany in 1913 (Frohner et al., 1913). The characteristic absence of
patches of epidermis on the limbs and hindquarters were described but the breed of horse in
which this occurred was not indicated. Hadley first proposed the name Epitheliogenesis
Imperfecta neonatorum (EI) as a distinct disease in cattle in 1928 (Hadley, 1928). Hadley
described several cases of hereditary defects in the epithelium of newborn Holstein calves. He
observed “defective formation of skin below the knee and hocks, defects in the integument of the
muzzle and in the mucous membrane of the nostrils, tongue, hard palate, and cheeks” (Hadley,
1928). Fifty cases of EI in Holstein herds were authenticated in the state of Wisconsin and the
defects were traced to Dutch herds in which similar cases were reported (Hadley, 1928).
The term Epitheliogenesis Imperfecta (EI) was first used in respect to horses in 1935 to
describe a similar epithelium defect in Ardennes foals in Sweden (Berthelsen et al., 1935). The
pathology (of the foal described) was identical to what is currently seen in Belgian Draft horses
and American Saddlebred horses in the United States. Based on a pedigree analysis and
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anecdotal evidence of the foaling of similarly affected foals, a genetic cause and recessive 
pattern of inheritance was proposed (Berthelsen et al., 1935). The work of Butz and Meyer in the 
1950’s described EI in Cold Blood horses in Germany and provided further evidence supporting 
an autosomal recessive pattern of inheritance (Butz et al., 1957).   
Butz and Meyer found that the survival time of EI affected foals varied from several 
hours to a few days after birth (Butz et al., 1957). They also noted that the locations of missing 
epidermis varied from foal to foal. Similar differences have been reported in EI affected foals in 
Saddlebred and Belgian horses. Butz and Meyer’s most important contributions were their 
breeding experiments. These experiments provided evidence supporting a recessive mode of 
inheritance for EI. In breeding experiments, a stallion that was a known carrier was bred to the 
daughters of a known carrier stallion and a non-carrier dam. Two of the eighteen offspring 
produced were EI affected foals. This gave an observed ratio of sixteen unaffected to two 
affected foals. This observed ratio was consistent with the expected ratio of fourteen unaffected 
to two affected animals for a recessive mode of inheritance (Butz et al., 1957). 
EI is an autosomal recessive, severely mutilating disease, which is characterized by the 
absence of skin on the hindquarters, forelimbs and/or hindlimbs of newborn foals. The 
progression of this disease is always fatal and affected foals are generally euthanized soon after 
birth. 
Epidermolysis Bullosa & Skin Structure 
 In the past decade, our understanding of the complex interactions involved in human skin 
structures has increased greatly. These interactions provide an excellent model to begin 
understanding the underlying defects that account for Epidermolysis Bullosa (EB) in humans and 
EI in horses. 
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Epidermolysis Bullosa refers to a class of mechanobullous diseases that share the 
common trait of blister formation after minor trauma to the skin. Historically, there were only 
three types of EB, which were classified based upon the ultrastructural location of the skin 
defects. These were the simplex, junctional and dystrophic types. In the past few years, greater 
understanding of skin protein interactions and the genetic basis of skin defects has led to the 
proposal of a fourth class of EB, the hemidesmosomal type (Pulkkinen and Uitto, 1998). 
EB simplex is the least severe type of EB and is usually accompanied by only minor 
blistering (Bonifas et al., 1991; Coulombe et al.,1991; Vassar, 1991). Skin lesions and severe 
blistering or bullous formation generally characterize junctional EB. The most severe and lethal 
forms of the junctional type were caused by mutations in laminin-5 protein subunits (Christiano 
and Uitto, 1996). Dystrophic EB can vary in severity from non-mutilating blisters to lethality 
depending upon the kind of mutation in the Collagen VII gene (Christiano et al., 1996). The 
fourth category, hemidesmosomal EB, is characterized by a tissue split at the boundary between 
the basal cell layer and the lamina lucida (Pulkkinen and Uitto, 1998). The ultrastructural defect 
is very similar to that of junctional EB and is generally differentiated from junctional EB by the 
particular protein in which the defect arises. 
 In humans the diagnosis of a specific type of EB is commonly based upon where the 
ultrastructural location of the skin separation occurs. Genetic and antibody tests usually are used 
in conjunction with transmission electron microscopy (TEM). However, TEM generally is 
accepted as the definitive technique for differentiating the four types of EB (Vogel et al., 1965). 
The histological appearance and structure of the skin is virtually identical, except for 
minor variations (pigment, follicular density), throughout mammalian species (Montagna, 1956; 
Trautmann, 1957). Given the overall similarity of the skin amongst mammals, it is reasonable to 
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presume that the underlying protein structure of the skin has a high degree of homology in 
mammals, in particular horses and humans. This supposition is supported by the considerable 
homology observed between skin proteins that have been sequenced in both mice and humans 
(Utani et al., 1995). 
Skin tissue is considered stratified squamous epithelium. This refers to the distinct layers 
of cells that are flattened in appearance. Human skin, like that of horses and other mammals, is 
constructed of three broad layers, which are identifiable through histological examination. If one 
views a cross section of skin, one sees the epidermis on the top of the section with a clear 
demarcation, called the basement membrane, separating it from the underlying dermis. Below 
the dermis lies the hypodermis. The separation between the dermis and the hypodermis is not as 
clear as that between the epidermis and the dermis. In fact, there is some disagreement among 
histologists about including the hypodermis as a separate layer in the skin (Fig.1). 
Each of these three layers has distinct characteristics. The hypodermis is predominantly 
composed of adipocytes and loose irregular connective tissue. The dermis is made up of dense 
irregular connective tissue and a capillary bed, which provides nourishment to the avascular 
epidermis. Separating the dermis and the epidermis is the basement membrane, which is made up 
of extracellular attachment proteins. 
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Figure 1. Organization of the Skin. 
 
 
Figure 2. Structure of the Skin. 
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 The topmost layer, the epidermis, is made up of four distinct layers or strata (Fig. 2). 
These layers are, from top to bottom, the stratum corneum, stratum granulosum , stratum 
spinosum and stratum germinativum or stratum basal. 
 The stratum corneum is the outermost layer and consists of flat, dead, keratinized cells. 
Underlying this layer is the stratum granulosum, which consists of a thin layer of somewhat less 
flattened cells. These cells contain the intensely staining keratohyalin granules, which form a 
lipid rich waterproof sealant in the stratum corneum. The third layer is the stratum spinosum, so 
named because of the appearance of spines radiating from the cells in light micrographs. These 
spines are actually artifacts from tissue preparation. The cells shrink during fixing and processing 
and the spines are the locations of desmosome binding sites. 
The stratum basal contains keratinocytes and melanocytes. The melanocytes possess the 
enzyme tyrosinase, which is required for melanin synthesis. The melanocytes are stellate cells 
with long processes through which they transfer vacoules of melanin called melanosomes to 
adjacent keratinocytes. The keratinocytes in the stratum basal are highly proliferative since they 
continually renew the upper layers of the epidermis.  
The layer between the stratum basal and the dermis is known as the basement membrane 
or the basal lamina. It is of particular interest because it is at this location that separations in the 
skin lead to the characteristic bullous and lesions of EB and EI. The basement membrane is made 
up of a plethora of extracellular proteins and proteoglycans that are involved in attaching and 
stabilizing the skin. Transmission electron microscope examination of the basal lamina reveals 
two zones (Fig. 3); the first is the lamina lucida, a pale layer, which immediately underlies the 
cells of the stratum basal. The second is an electron dense layer immediately above the 
connective tissue of the dermis called the lamina densa. Within the basal cc it is possible to see 
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periodic structures called hemidesmosomes. These structures are the primary adhesion structures 
of the basal lamina and provide attachment between the epidermis and the dermis.  
 
Figure 3. Horse Skin, Ultrastructure of the Basement Membrane 
 
The defining characteristic of all types of EB is a physical separation of the skin that 
results in a mechanobullous formation. The breakage occurs within the basal lamina or adjacent 
cell layers. The location of the separation within the basal lamina is specific for each type of EB. 
In the simplex EB subtype, tissue separation occurs within the epidermal basal 
keratinocytes adjacent to the basal lamina. This results in the formation of a bullous with ragged 
roof and an intact basal lamina attached to the underlying dermis. Defects in several proteins can 
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lead to variants of simplex EB with a range of severity of symptoms. These proteins include 
keratin intermediate filaments 5&14, BP230 and plectin. Junctional EB blister formation arises 
within the lamina lucida of the basal lamina. This results in a relatively clean break and a bullous 
with a roof of intact epidermal keratinocytes. Defects in or lack of function in the laminin 5 
protein causes junctional EB. In junctional EB the lamina densa remains attached to the 
underlying dermis. Hemidesmosomal EB is defined by tissue separation between the basal cells 
of the epidermis and the lamina lucida (Pulkkinen and Uitto, 1998). The defects that cause 
hemidesmosomal EB were at one time considered variants of junctional EB. Abnormalities in 
B180 or either of the α6β4 integrin subunits can lead to hemidesmosomal EB. Dystrophic EB is 
identified by tissue cleavage at the dermal side of the basal lamina within the lamina densa. This 
also results in a fairly clean break with the lamina lucida still attached to the epidermal roof of 
the bullous. All of the dystrophic forms of EB currently identified are due to collagen VII 
defects. 
These four types of EB are caused by defects within proteins associated with the 
hemidesmosome attachment structure. The particular subtype of EB and the severity of 
symptoms are directly related to the location of the mutated protein and to the type of mutation. 
Genetic mutations which result in truncated or nonexpressed proteins lead to a more severe 
pathology than mutations which result in a defective yet functional protein. One of the most 
severe variants is Herlitz Junctional Epidermolysis Bullosa (HJEB). This variant of the 
junctional subtype is lethal and is characterized by wide spread lesions in newborn humans. 
Disease symptoms also include dental abnormalities, oral, anal-genital and ocular lesions.  
Equine EI shares a similar pathology with Epidermolysis Bullosa (EB) in humans, 
specifically HJEB. Necropsies performed on two American Saddlebred foals revealed extensive 
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areas lacking an epidermis as well as dental deformities, oral mucosa lesions and genital lesions. 
Similar signs were observed in Belgian foals (Johnson et al., 1988; Kohn et al., 1989).  
Extensive work has been done in humans to elucidate the interactions that make up the 
hemidesmosomal adhesion complex. The human model of basal lamina attachment provides an 
excellent illustration of structures that, quite likely, share a high degree of homology to those in 
the horse. 
Hemidesmosomes are attachment structures that attach epidermal basal cells to the basal 
lamina in stratified and complex epithelia (Fig.4). Within the basal keratinocytes, the keratin 
intermediate filaments form the major points of attachment with the hemidesmosomal plaque. 
This plaque includes plectin and BP230, which interact with transmembrane proteins, stabilizing 
and aggregating them. Projecting from the hemidesmosomal plaque through the plasma 
membrane are the transmembrane proteins BP180 and the heterodimer α6β4 integrin. In turn, 
they bind with laminin 5, which is the primary constituent of the anchoring filaments. The 
anchoring filaments associate with thicker filamentous structures called anchoring fibrils. These 
fibrils are made up of the homotrimer collagen VII. The anchoring fibrils originate in the dermis 
and extend through the lamina densa to the anchoring plaques. 
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 Within the cytoplasm of  basal epidermal cells the hemidesmosome plaque is easily 
observed in transmission electron micrographs (Fig 3). This plaque is primarily made up of the 
proteins, bullous pemphigoid antigen 230 (also known as BP230 or BPAG1) and plectin. These 
two proteins stabilize and anchor the complex to the intracellular cytoskeleton by binding to the 
keratin intermediate filaments (Borradori, 1999; Green et al., 1992; Buck et al., 1983). Plectin is 
identical to the 500 KD protein HD1 (Okumura et al., 1999). BP230 and plectin are members of 
the plakin family, a group of broadly expressed proteins involved in cytoskeletal associations 
(Wiche, 1998) (Fig 4). 
The epidermal isoform of BP230 binds to intermediate filament proteins via its C 
terminus. (Leung et al., 1999; Yang et al., 1996). These interactions most likely take place 
through the B and C homologous subdomains of the C terminal end of BP230 (Fig 5) (Green et 
al., 1992). Evidence indicates that BP230’s N terminus interacts with the cytoplasmic domain of 
BP180/Collagen17 (Borradori et al., 1998 ). The transmembrane protein BP180 is associated 
with the hemidesmosome attachment structure and can bind laminin 5. 
Plectin is a member of the spectrin superfamily of actin binding proteins and shares with 
them a conserved actin binding domain (ABD) near its N terminus (Fig 5) (Hartwig, 1994). The 
C terminus of plectin contains six tandem repeat domains (R1-R6) of which the fifth repeat binds 
to intermediate filaments (Rezniczek et al., 1998). Cytokeratins 5 and 14 bind to plectin at the 
fifth repeat and play an important role in connecting the hemidesmosomal plaque to the cell's 
cytoskeleton (Rezniczek et al., 1998).  
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Figure 5. Skin Attachment Proteins.  
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It has been suggested that plectin can associate with BP180 and influence it’s location 
(Gache et al., 1996; Aho et al., 1999; Schaapveld et al., 1998). At this point we can begin to 
envision the cytoplasmic structure of a typical hemidesmosome. The 500 kD protein, plectin, 
binds keratin intermediate filaments through globular repeats near it’s C terminus, of which the 
fifth repeat has been shown to be important (Nikolic et al., 1996). Closely associated with plectin 
is BP230, which binds to keratin intermediate filaments through its C terminus and to the 
cytoplasmic portion of transmembrane protein BP180 through its N terminus. Plectin binds to the 
cytoplasmic portion of the β4 subunit of the α6β4 integrin via plectin’s N terminus. This binding 
to the β4 subunit inhibits plectin from binding to actin via its ABD domain (Geerts et al., 1999).  
The α6β4 integrin spans the plasma membrane and is found in hemidesmosomes where 
keratin intermediate filaments attach (Stepp et al., 1990; Tamura et al., 1990). The β4 subunit is 
a 200 kD protein with two pairs of type III fibronectin (FN) repetitions separated by a connecting 
segment (CS). Mutation studies have shown that the second FNIII repetition is required for 
binding to plectin (Geerts et al., 1999). Yeast two hybrid studies have revealed that the strongest 
interactions between β4 and BP180 require both the third FNIII and a stretch of 27 amino acids 
of the CS (Fig. 5) (Schaapveld et al. , 1998). The α6β4 integrin serves as the primary connecting 
molecule, which links the hemidesmosome plaque with laminin 5 (previously known as nicein, 
kalinin, or epiligrin). 
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Figure 6. Laminin 5. 
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 Laminin 5 is a cruciform shaped heterotrimer made up of α3, β3 and γ2 chains (Fig 6). 
These chains contain globular domains flanked by epidermal growth factor (EGF) like repeats. 
The laminin 5 molecule supports cell adhesion and migration; it is the only laminin currently 
identified which contains the γ2 chain. The laminin 5 molecule most likely associates with α6β4 
through the G domain of the laminin 5 α3 chain and is conformation dependent (Rousselle et al., 
1995; Champliaud et al., 1996). Laminin 5 does not bind nidogen due to amino acid differences 
in its γ2 chain from the more common γ1 chain (Mayer et al., 1995). Nidogen is a 150 KD 
glycoprotein, which binds to laminins containing a γ1 chain (Mayer et al., 1993). Nidogen can 
self associate, bind to laminins (with the γ1 chain) and bind to collagen IV (Mayer et al., 1994). 
Collagen IV binds to itself to form a network, which is found in basement membranes 
throughout the body. Since laminin 5 contains the γ2 chain, instead of the more common γ1 
chain, it fails to interact with the collagen IV network. 
Due to a lack of short arm domains, which are believed to be necessary for self-
association, laminin 5 is likely to have an inherently monomeric form. The laminin 5 protein 
interacts with the NC1 domain of collagen VII most likely through its β3 and γ2 chains 
(Rousselle et al., 1997). Laminin 5 also interacts with the α3β1 integrin, an important component 
of actin associated focal adhesion contacts (Carter et al., 1990; Carter et al., 1991; Delwel et al., 
1994). These contacts play an important role in cell migration, especially in response to 
wounding. Injury to the skin causes the synthesis of several extracellular proteins, notably 
laminin 5, to be upregulated. Laminin 5 plays an important role in both epidermal cell 
attachment and migration (Carter et al., 1991; Zhang and Kramer, 1996; O’Toole et al., 1997) 
Within hemidesmosomes, laminin 5 anchoring filaments  interact with Collagen VII 
anchoring fibrils at the interface between the lamina lucida and the lamina densa. These fibrils 
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originate in the dermis and terminate in the lamina densa. The Collagen VII protein is a 
homotrimer composed of three identical pro α chains. The N terminal 145 kD non-collagenous 
(NC1) domain interacts with laminin 5. Collagen VII also has a 145 kD central collagenous 
domain and a C terminus 30 kD non-collagenous domain (NC2) (Christiano et al., 1994a). With 
118 exons; the Collagen VII gene (COL7A1) has the dubious honor of having the most exons 
identified to date (Christiano et al., 1994b). 
 The attachment structures, which bind the epidermis to the dermis, do so in a complex 
fashion that is incompletely understood. The picture which emerged from the evidence gathered 
to date suggests that each of the proteins involved in the hemidesmosome structure play a crucial 
role in maintaining it’s integrity. In humans with EB, we can clearly see the severity of the 
consequences for skin integrity when one of the hemidesmosomal proteins is truncated or absent. 
The most severe subtype of EB is the Herltiz variant of Junctional EB. This subtype is caused by 
a premature stop codon in one of the three subunits in laminin 5 chain (Aberdam et al., 1994; 
Ashton et al., 1997; Baudoin et al., 1994). 
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Gene Mapping-Linkage Analysis 
 Linkage analysis is a recognized way to establish a relationship between a disease 
phenotype and a specific gene. Linkage analysis studies require genetic information from 
families in which the disease occurs. The family members are tested for evidence of markers that 
are located near or within the candidate gene. This methodology has proven successful in 
humans in providing evidence for a genetic association between specific EB subtypes and their 
respective candidate genes(al-Imara et al., 1992; Dunnill et al., 1994; Torrelo et al., 1998).  
 A general approach to performing a linkage analysis involves several steps. First, one 
must know the mode of inheritance. Second, it must be possible to identify the disease status of 
individuals from whom DNA is available. Third, the family size must be large enough to make 
the results statistically significant. In general this requires a minimum of ten informative meioses 
for dominant traits to give a LOD score (Logarithmic ODds ratio) greater than +3 for theta equal 
to zero (Dear, 1997). The LOD score expresses the probability that the pattern of segregation 
occurs by chance (unlinked) versus the probability that the pattern of segregation is due to 
linkage (Dear, 1997). The LOD score is expressed as a base 10 logarithm of the probability. A 
LOD score of 3 corresponds to a probability of 0.001 and is the generally acknowledged standard 
for accepting linkage. 
 Fourth, markers should be chosen with a sufficient number of polymorphisms to make 
them informative. Microsatellites are DNA markers useful for this type of analysis (Weber et al., 
1993). Microsatellites are repetitive lengths of DNA whose repeat unit length can vary from 2 to 
5 nucleotides. In horses almost all of the polymorphic microsatellites, identified to date, consist 
of dinucleotide repeats (for examples see Coogle et al.,1996a; Irvin et al., 1998; Lindgren et al., 
1999). 
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 Fluorescently labeled microsatellites can be easily screened through automated 
genotyping techniques. Linkage analysis of fluorescently labeled microsatellites was successfully 
used to show association of microsatellite markers to equine combined immunodeficiency 
disease in horses (Bailey et al., 1997).  
A concerted equine genome-mapping project began in 1995 when The First International 
Workshop for Equine Genome Analysis was convened in Lexington, KY. Since then, significant 
progress has been made in assigning markers to equine chromosomes and establishing 
relationships with homologous human chromosomes. According to the Horse Map Database, 
there are currently 383 map assigned microsatellites distributed across 33 chromosomes (32 pairs 
of autosomes and the X and the Y chromosomes). 
 Several different approaches have been used to assign chromosomal locations to both 
coding (genes; type 1 markers) and microsatellite (type 2) markers. These include synteny 
mapping, in situ hybridization, radiation hybrid mapping and linkage mapping in conjunction 
with physical mapping (Bailey et al., 1995; Kiguwa et al., 2000; and Swinburne et al., 2000).  
  The first direct synteny study in the horse was undertaken in the early 1990s. In this study 
three syntenic groups were identified with eight enzyme genes (Williams et al., 1993). Syntenic 
genes are genes located on the same chromosome and asyntenic genes are genes located on 
different chromosomes (Renwick, 1971). Since the early 1990’s, three more synteny panels have 
been reported (Bailey et al., 1995; Raney et al., 1998; Shiue et al.,1999). All of these panels were 
constructed by fusing horse and mouse cells to create somatic cell hybrid clones. More than 500 
markers have been mapped using these synteny panels (Bowling et al., 1997; Caetano et al., 
1999). In order to assign each synteny group to a specific horse chromosome Shiue et al. (1999) 
included a marker in each group that had been previously mapped to a chromosome using FISH. 
 19 
This integration of synteny data with physical location established the first framework map of the 
horse genome (Shiue et al., 1999). 
In the technique of fluorescent in situ hybridization (FISH), DNA probes are bound to 
metaphase chromosomes. Just before cell division the chromatin, the compact structural form of 
DNA, condenses further into individual metaphase chromosomes. Metaphase chromosomes are 
the structures that are stained to depict the karyotype banding patterns of chromosomal 
appearance. The physical position to which each labeled probe binds provides information on the 
chromosome and chromosomal subregion location of the target of the probe (for examples see 
Godard et al., 1997; Breen et al., 1997; Lear et al., 1999). A variation of in situ hybridization 
called fluorescent labeled heterologous species chromosome painting (ZOO-FISH) also was used 
to identify homologies between human and horse chromosome regions (Lear et al., 1997; 
Raudsepp et al., 1996). In ZOO-FISH one uses fluorescently labeled DNA from entire 
chromosomes or parts of chromosomes of one species to hybridize to chromosomes of another 
species. Initially, this technique relied on using human whole chromosome paints (WCP) to 
probe horse metaphase chromosomes (Raudsepp et al., 1996; Rettenberger et al., 1996; Lear et 
al., 1997). Hybridizations with WCPs proved quite useful. However, not all equine chromosomes 
fully hybridize with human WCPs. The use of sub-chromosome paints has revealed that some 
equine chromosomes have regions homologous to multiple human chromosomes (Chaudhary et 
al., 1998). 
The ZOO-FISH map allows genes that have a known location on a human chromosome 
to be putatively assigned to equine chromosomes and in some cases to a specific chromosomal 
arm. This is important because it permits the identification of microsatellites specific to a 
chromosome or sub region for further study.  
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Two radiation hybrid panels have recently been developed for the horse and are currently 
being analyzed. These panels were developed separately at Texas A&M (Skow, 2000, Personal 
Communications) and at Cambridge University (Kiguwa et al., 2000). Radiation hybrid panels 
are developed by irradiating cells containing the genome of interest with ionizing radiation and 
then fusing them with rodent cells. The radiation breaks the chromosomes into pieces whose size 
depends (in part) on the intensity of the radiation exposure. High levels of radiation produce 
smaller fragments and greater mapping resolution. The advantage of using radiation hybrid 
panels is that non-polymorphic, type 1coding markers can be mapped in addition to type 2, non-
coding polymorphic markers. Physical distances can be determined for these markers as well as 
syntenic group assignment.  
Linkage analysis, in conjunction with physical mapping, is the current method whereby 
markers are assigned to a chromosome and distances between the markers are measured. In this 
method, linkage analysis is performed on members of a family using a group of markers. The 
markers are assigned to linkage groups based on their LOD scores. Then, one or more members 
of the linkage group are physically located on a chromosomal region using FISH mapping. This 
allows assignment of a linkage group to a specific chromosome and provides information on the 
distribution and location of the markers within the group. The first equine linkage map was 
reported by Lindgren et al., (1998) in which 140 markers were tested. Twenty-five linkage 
groups were identified. These were assigned to 18 chromosomes and had an average distance 
between markers of 12.6 centimorgan (cM) with the map covering 679 cM.. 
The International Equine Gene Mapping Workshop reported a linkage map of 161  
mapped markers(Guerin et al., 1999). These were placed in 29 linkage groups assigned to 26 
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autosomes (Guerin et al., 1999). The average marker distance was 14.2 cM and the map distance 
spanned was 936cM (Guerin et al., 1999). 
Swinburne et al. (2000) reported 359 markers assigned to 42 linkage groups on all 31 
autosomes and the X chromosome. The average interval between markers was 10.5cM and the 
total distance covered was 1780cM. The increase in marker density improves the likelihood of 
identifying a marker that is linked to a candidate disease gene. 
 The average total map distance in mammals is estimated to be 3000cM “(as reviewed in 
Murray and Bowling, 2000)”. This indicates that the current equine genome map covers less than 
two thirds of the total horse genome. Coverage also varies from chromosome to chromosome. 
Some, such as ECA1, have a high number of markers many of which have been physically 
mapped (Swinburne et al., 2000). Other chromosomes, such as ECA28, only have 1 marker 
assigned to them (Swinburne et al., 2000). 
Linkage Disequilibrium 
 Linkage analysis measures co-segregation of a marker with a gene within a family. 
Analysis of linkage disequilibrium (LD) allows one to measure association of alleles at different 
loci within an entire population. In diploid organisms, recombination occurs during meiosis. The 
two copies of each chromosome pair and their DNA strands physically crossover, break and 
recombine. The chromosomes exchange homologous regions of DNA, thus the two resultant 
chromosomes have the same genes but not necessarily the same alleles as the parent 
chromosome.  
Recombination does not change the linear order of genes. However, it changes the 
original association of alleles on the strand of DNA. Under Hardy-Weinberg equilibrium 
expectations, alleles are associated at random and as products of their genotypic frequencies in 
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the population. When the association of alleles for linked loci is found to be non-random at the 
population level, Hardy-Weinberg expectations are not met and the alleles are said to exhibit LD. 
LD identification of a physically mapped marker with a disease locus provides 
information on the chromosomal location of the disease locus. If the disease mutation lies very 
close to the marker loci then the ancestral marker allele which occurred in a founder bearing the 
mutation most likely will remain associated with the disease. The distance between the marker 
and the disease gene as well as the time since origin of the mutation determines the strength of 
the association. 
 This method does not require family data, as does linkage analysis, in order to study 
inherited diseases. In this case, one expects that a marker that is close to a disease causing 
mutation would have a lower frequency of recombination than random expectations in relation to 
the disease gene and that the haplotype should be preserved. For recessively inherited diseases, 
this means that the affected individuals should be homozygous for both the disease gene and a 
closely linked marker. For diseases that have a single origin in a population, affected individuals 
may be homozygous for a single allele of a marker closely located to the disease locus. By 
testing markers likely to be near a candidate gene, it is possible to detect these differences in 
allelic distributions and measure their statistical significance. 
Widespread LD has been observed in cattle with effects measurable across distances less 
than 5cM (Farnir, 2000). One centimorgan is estimated to be equal in length to one million bases 
(megabase) of DNA (Kimball, 2000). Based on the observed disequilibrium in cattle it was 
predicted that 1,500 markers would be adequate for LD screening in cattle (Farnir et al., 2000). 
This compares very favorably to humans, where it has been estimated that informative levels of 
LD are unlikely to extend beyond 3kb (Kruglyak et al., 1999).  
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cDNA Libraries 
 Sequencing a candidate gene and finding a mutation that modifies it is strong evidence 
that the mutated gene is responsible for disease. One method of obtaining the sequence of a gene 
of interest is to construct a phage (bacterial virus particle) library containing a collection of 
cDNA fragments from a particular tissue. This phage library is referred to as a cDNA library. 
cDNA stands for complimentary DNA and is a DNA duplicate of a mRNA transcript. cDNA 
libraries are only representative of the messenger RNA’s present in the tissue from which they 
are constructed. It is, therefore, important to be certain that the tissue from which the library is 
constructed transcribes the gene, or genes, of interest. Messenger RNA undergoes splicing after 
transcription which removes noncoding or intronic DNA and splices together the remaining 
DNA or exons.  
 To construct a cDNA library the cDNA is ligated into a phage vector and then packaged, 
in vitro, within the vector’s protein coat. The phages are then transfected into an E. coli strain of 
bacteria. The phages reproduce and lyse the bacteria producing small round plaques on a lawn of 
bacteria. Individual plaques represent an insert that has been cloned. 
Systematic sequencing and mapping of cDNA clones has been significantly improved in 
the last ten years through the use of fluorescent sequencing methods in combination with partial 
sequencing of cDNA ends (Adams et al., 1991; Smith et al., 1986). These cDNA ends are known 
as expressed sequence tags or EST’s. They are short, usually single strand sequences which 
identify (or tag) a specific clone (Adams et al., 1991). ESTs provide an opportunity to ascertain 
the identity of pieces of genes with interspecies homologues by database comparison searches. 
They can be sequenced from either the 3’ or 5’ end. However, in directional libraries primed 
with oligo dT’s (oligonucleotides, consisting of dTTP’s, (deoxy Thymine Tri-Phosphates)) used 
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as a primer for cDNA synthesis) 5’ sequencing is more likely to produce sequence data which 
can be identified with homologues in other species via database search (Kwak, 1996). This is due 
to the presence of the 3’ untranslated region (UTR), which is not removed during splicing. The 
3’ UTRs are not usually homologous between genes or across species. This makes them almost 
useless for identifying clones by database searching. Oligo dT’s only attach to the 3’Poly A tail 
of mRNA’s so that Reverse Transcription Polymerase Chain Reaction (RT PCR) produces single 
strand cDNA’s that mirror the mRNA strand and incorporates the oligo dT, thus retaining the 
orientation of the mRNA. 
Directional libraries are constructed so that the 5’ to 3’ orientation of the cDNA insert is 
preserved. This allows expression of a functional protein if the insert is full length. cDNA 
synthesis from mRNA or RT PCR, can be primed using an oligo dT primer or random oligomers 
(hexamers, decamers, etc.). The advantage of using oligo dT primers for RT PCR is that the 
orientation of the mRNA is preserved by the nascent cDNA. The advantage of using random 
oligomers for RT PCR is that, since they bind randomly to the mRNA, the cDNA’s to which 
they prime have a slightly higher chance of being identified by database search (Kwak et al., 
1996). cDNA libraries constructed with random hexamers also will represent the few mRNA’s 
which can lack a poly A-tail, such as histones (Greenberg et al., 1972). The disadvantage of 
using random hexamers is that they are more likely to prime cDNA synthesis of ribosomal and 
transfer RNA, which can contaminate the library. 
 Sequencing random ESTs is a fast and efficient way to obtain a substantial amount of 
gene data. The data is useful for identifying sequences homologous to genes stored in databases 
as well as for describing the library from which it came. Once identified, ESTs are easily mapped 
on radiation hybrid panels. This allows the rapid assignment of the location of genes without 
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knowing their full sequence. The ESTs provide information on the numbers and types of 
transcripts present in the cDNA library.  
 EST’s have been used for comparative mapping in cattle as part of a strategy known as 
comparative mapping by annotation and sequence similarity (COMPASS)(Ma et al., 1998). 
Primers designed from EST’s produced from a cattle ovary library were screened on a somatic 
cell hybrid panel. The chromosome assignments for the EST’s were consistent with the bovine 
comparative map(Ma et al., 1998). Production of EST’s is an efficient way to produce a tool with 
a variety of uses in mapping, comparative mapping and gene identification. 
Objectives and Goals 
 Previously published work on EI in cold blood horses in Europe suggested that EI 
was an autosomal recessive disease. Based on this work it was hypothesized that EI in American 
Saddlebred horses was a recessive genetic condition. Although it was not possible to conduct 
breeding experiments, this hypothesis was tested by construction of a partial pedigree of families 
with affected individuals and examination of breeding records related to EI within the American 
Saddlebred horse breed. Second, using the human disease HJEB as a model it was hypothesized 
that Equine EI shared a similar defect in ultrastructure. TEM examination of the ultrastructure of 
skin from EI affected foals revealed that the skin separation occurred within the lamina lucida 
where laminin 5 is located. Third, it was hypothesized that the ultrastructural defect was caused 
by a mutation within one of the genes coding for the laminin 5 subunit which resulted in a 
defective or absent protein subunit and a loss of function for the laminin 5 heterotrimer. Results 
from the LD analysis suggested that the LAM α3 subunit was the EI disease gene within the 
American Saddlebred horse breed. Finally, a cDNA library was constructed to serve as resource 
for sequencing the LAM α3 gene.  
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Chapter Two 
Pedigree Analysis 
 
Introduction  
In recent years, improved education and public awareness of EI has increased the number 
of reported cases in Belgian Draft horses and American Saddlebred horses. Despite the relative 
rarity of the disease, greater recognition of the graphic nature of EI by breeders and the relevant 
registries has led to an increased interest in developing a test to screen for carriers of this disease.  
Based on pedigree information provided by the American Saddlebred Horse Association 
(ASHA) it was possible to assemble a partial pedigree showing relationships of the EI affected 
foals and carriers. 
 
Materials and Methods 
 Seventeen individual ASHA pedigrees of EI affected foals and a case report from the 
ASHA describing the parturition of seventeen other EI affected foals (for a total of 34 EI affected 
foals) were used to assemble a partial pedigree showing likely lines of inheritance of EI in 
Saddlebred horses. Local veterinarians classified horses as carriers if they had an EI foal that was 
identified based on external pathology. The pathological signs that are indicative of EI include 
broad lesions of missing skin on the legs and/or body, oral mucosa lesions and genital lesions. 
These occurrences of EI foals were reported to the ASHA and the parents of the foals were 
identified. The majority of the individual pedigrees obtained from the ASHA used in this 
pedigree contained a written pathological report and pictures confirming the diagnosis of EI. The 
case report did not contain specific pathological reports. However, the report cited the basis on 
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which a diagnosis of EI was made for each case included within. These citations referenced one 
or more of the following; pathology reports on file with state veterinary hospitals, diagnoses 
made by specific veterinarians or reports made by owners of one or both parents of the EI foal. 
The horse’s names were not used in order to maintain confidentiality 
 
Results  
One hundred and thirty five registered horses are represented on this partial Saddlebred 
pedigree (Fig. 7). Black symbols indicate animals that are not known to be carriers. Red symbols 
represent horses that have parented at least one EI foal and are therefore known to be carriers. A 
red X indicates an affected EI foal. A red X with a red number indicates the number of EI 
affected foals from a particular cross. A red X with a green number indicates a foal that was used 
in the Linkage Disequilbrium analysis in Chapter 6. In interactions where a sire was bred to 
multiple dams resulting in multiple offspring an N has been attached to the marker. The earliest 
reported cases of EI in Saddlebred horses in this pedigree are the two matings between sire 26 
and 36, that occurred in 1975 and the following year.  
 The genotypic frequency of EI was estimated for the American Saddlebred horse 
population based on the average yearly number of Saddlebred foals registered by the ASHA 
(~3000) divided by the number of EI affected foals reported to the University of Kentucky (5) in 
1998. The allelic frequency was computed by using Hardy-Weinberg and taking the square root 
of the genotypic frequency (.0016). This resulted in an estimated allelic frequency of 0.04 for EI 
in the American Saddlebred horse population.  
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Discussion 
 Twenty-eight of the 34 cases of EI affected foals reported by the ASHA were placed in 
this pedigree (Fig. 7). The remaining six were part of the ASHA case report and their ancestry 
was not identified. Lines of transmission clearly can be seen from sire 26 and sire 44. Both mares 
and stallions are carriers and contribute to the appearance of EI. However stallions can have 
multiple offspring every year and so contribute more significantly to the spread of the disease 
gene throughout the population.  
 The pedigree evidence is consistent the work of Butz et al., (1957), which indicated that 
EI is an autosomal recessive trait. Simple recessive traits must be homozygous in order for the 
phenotype to be expressed, thus EI affected foals are presumed to be homozygous for the EI 
mutation. Based upon the average number of EI affected foals born per year and Hardy 
Weinberg expectations, a frequency of 0.04 was estimated for the EI allele. Examination of the 
foaling records of stallion 70 in the pedigree provided support for this estimate. With an 
estimated EI allele frequency of 0.04 and presumed random mating a genotypic frequency of 
0.077 was calculated for the heterozygous EI carriers using Hardy-Weinberg. Stallion 70 had 
107 registered offspring according ASHA records (all of which are not shown on the pedigree) 
and 3 known EI affected foals for a total of 110 known offspring. By multiplying the estimated 
genotypic frequency of 0.077 by 110 matings it was predicted that Sire 70 would be mated to 
carriers ~9 times which should result in ~2 EI affected foals. The 3 EI affected foals produced by 
stallion 70 fist this expectation of ~2 foals under a recessive mode of inheritance. 
 The pedigree indicates that all EI affected foals of known ancestry can be traced to a 
single lineage. This is consistent with a single individual being responsible for the spread of EI 
within Saddlebred horses. It was not possible to identify a specific putative founder with the 
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incomplete pedigree data available. Even with the availability of a full studbook, any errors in 
pedigree assignment would make the identification of a single founder unreliable. However, a 
single source of EI in Saddlebred horses would mean that all of the carriers and EI affected foals 
have the same causative mutation. This would mean that the American Saddlebred horses would 
be genetically homogeneous for EI. 
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Chapter Three 
Morphology and Histology 
 
Introduction 
The pathological signs that came to be known as Epitheliogenesis Imperfecta were first 
described in horses in Germany in 1913 (Frohner et al., 1913). Hadley first proposed the name 
Epitheliogenesis Imperfecta neonatorum (EI) as a distinct disease in 1928 (Hadley, 1928). Hadley 
described several cases of hereditary defects in the epithelium of newborn calves.  
The term Epitheliogenesis Imperfecta was first used in respect to horses in 1935 to 
describe a similar epithelium defect in Ardennes foals in Sweden. (Berthelsen et al., 1935). The 
pathology of the foal described was identical to what is currently seen in Belgian horses and 
Saddlebred horses. Based on a pedigree analysis and anecdotal evidence of the foaling of 
similarly affected foals a genetic cause and recessive pattern of inheritance was proposed 
(Berthelsen et al., 1935). The work of Butz and Meyer in the 1950’s described EI in European 
cold blood horses in Germany and provided further evidence supporting an autosomal recessive 
pattern of inheritance (Butz et al., 1957). 
Butz and Meyer found that the survival time of EI affected foals varied from several 
hours to a few days after birth (Butz et al., 1957). They also noted that the locations of missing 
epidermis varied from foal to foal. Similar differences were observed in EI affected American 
Saddlebred and Belgian Draft foals that were reported to the University of Kentucky.  
 EI is a lethal disease that has a dramatic pathology in newborn foals. Patches of missing 
skin in newborn foals along the hindquarters and legs (Fig. 8) are common to this disease. 
Through the assistance of interested breeders, veterinarians and the support of several breed 
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registries or organizations it has been possible to collect samples from sixteen EI Belgian and 
Saddlebred foals over the past few years. The collection of two EI Saddlebred foals in 1999 was 
of particular importance because it provided the opportunity to perform full necropsy 
evaluations.  
 
Figure 8. Archival photo of an EI affected American Saddlebred foal.
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Materials and Methods 
Two female EI affected Saddlebred foals were collected within four hours post 
euthanasia. These were EI affected foals 2 and 7 as identified in Chapter Two, Figure 7. The 
foals presented with the classic signs of EI. They were bagged in plastic, covered in ice and 
transported back to the University of Kentucky Dimock Animal Pathology building where full 
necropsy and histological examinations were performed under the supervision of Dr. Thomas 
Swerczek, University of Kentucky Animal Pathologist. 
Necropsy 
External lesions on the legs and body of the foals were photographed. The heads of both 
foals were sectioned to provide access to the mouth. Oral mucosa lesions and dental 
abnormalities were photographed. The internal organs were also examined for abnormalities. 
The esophagus, stomach and intestines (upper and lower) were examined both externally and 
internally for signs of malformation or blockage. The remaining organs associated with the 
digestive system (liver, pancreas, and gall bladder), the immune system (spleen, thymus), cardio-
pulmonary system (heart, lungs) and the kidneys were also examined. Samples from the liver, 
kidney, spleen, thymus, lung and brain were removed for slide preparation by the University of 
Kentucky Livestock Disease Diagnostic Center using standard methodology (Thompson et al., 
1966). Tissues were fixed in 10% neutral buffered formalin for at least 24 hours. The tissues 
were then washed in running water before dehydrating in 80%, 95% and absolute alcohol, 
cleared in xylene and embedded in paraffin. Tissues were sectioned 6 microns thick and mounted 
on 1x3 glass slides. The sections were deparaffinized through 2 changes of xylene, absolute 
alcohol, 95% alcohol, tap water and distilled water before staining. The tissues were stained with 
Hematoxylin and Eosin using standard techniques and then mounted in permount.  
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Results 
Both Saddlebred foals presented with missing epidermis along their extremities and on 
other body locations (Figs. 9&10). A clear separation of the epidermis from the dermis can be 
seen at the level of the basement membrane (Fig. 26). Both foals had signs of abnormal dentition 
as well as lesions along their tongue, gum line, hard palate and soft palate (Figs. 11-14). Lesions 
were also observed on the exterior of the anus and genitals (Figs. 15&16). Physical examination 
of the body cavity revealed organs normal in appearance. No blockages or signs of pyloric 
atresia were observed in the digestive tract of either foal. The internal appearance of the 
esophageal lining and stomach was normal and showed no signs of necrosis.  
 Histological examination of several internal organs by myself and verified by Dr. 
Thomas Swerczek revealed no signs of structural defects (Figs 17-24). Inspection of the liver, 
kidney, spleen, thymus, lung and brain displayed physical structures consistent with those 
expected in a newborn foal. Dental examination showed teeth defects similar to those previously 
reported in Saddlebred horses by Dubielzig et al. (1986). The teeth were irregular and rough in 
appearance with jagged edges (Figs.13&14).  
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Figure 9. EI Saddlebred Foal (2) skin 
lesion along back and hindquarters. 
Figure 10. EI Saddlebred Foal (1) skin 
lesion. Note that almost the entire 
forelimb is missing epidermis. 
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Figure 11. EI Saddlebred Foal (2) oral mucosa lesions. 
 
Figure 12. EI Saddlebred Foal (1) oral mucosa lesions. 
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Figure 14. EI Saddlebred Foal (2) dorsal/ventral section. Note the lesions along the base 
of the tongue and the gum line. 
 
Figure 14. EI Saddlebred Foal (1) oral mucosa lesions, sagittal section. Note the lesions 
along the top of the hard palate. 
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Figure 15. EI Saddlebred Foal (2) Anus lesion. 
 
Figure 16. EI Saddlebred Foal (1) Vaginal lesion. 
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 Figure 17. EI Saddlebred Foal (1) Thymus. 
 
Figure 18. EI Saddlebred Foal (2) Thymus. 
 
Figure 19. EI Saddlebred Foal (2) Spleen. 
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Figure 20. EI Saddlebred Foal (1) Lung. 
 
Figure 21. EI Saddlebred Foal (2) Lung. 
 
Figure 22. EI Saddlebred Foal (2) Brain tissue. 
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Figure 23. EI Saddlebred Foal (1) Kidney. 
 
Figure 24. EI Saddlebred Foal (1) Micro bullous split in skin. 
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Discussion 
 The missing patches of epidermis, oral mucosa lesions and lack of intestinal 
blockages observed in these two EI affected American Saddlebred foals are consistent 
with those seen in Herlitz Junctional EB in humans. The skin lesions seen in EI affected 
foals (Figs. 8, 9& 10) are quite similar to those observed in human neonates (Figs. 
25&26) with junctional EB. Necropsy and histological examination failed to reveal any 
signs of intestinal blockage or internal organ abnormalities in the Saddlebred EI affected 
foals (Figs. 17-24). The lack of pyloric atresia and the severity of the skin lesions are 
incompatible with any of the simplex or hemidesmosomal variants of EB. Wide-spread 
lesions on the skin and oral mucosa have been observed in some of the more serious 
variants of dystrophic EB. However they are not generally observed in neonates in 
humans until after birth. Given that both junctional EB and dystrophic EB are possibly 
consistent with the disease pathology further assessment of the nature of this disease was 
undertaken. 
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Figure 25. Human Infant with lesions due to Junctional Epidermolysis Bullosa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Human Infant with Epidermolysis Bullosa. Note the bilateral 
lesions on the lower extremities similar to those observed in EI affected 
foals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Images used with permission by Lawrence S. Chan, M.D., Northwstern University 
  44 
Chapter Four 
Transmission Electron Microscopy 
 
Introduction 
Transmission Electron Microscopy (TEM) is a well-established method of examining 
skin samples for ultrastructural defects. In human medicine, TEM has long been the standard 
method for differentiating EB from other bullous skin disorders and for identifying the particular 
subtypes of EB (Vogel et al., 1965). The three classical subtypes of EB (Simplex, Junctional, 
Dystrophic) can normally be recognized by the location of their bullous formations. In recent 
years modern technology and a better understanding of the genetic basis of EB has, in many 
cases, allowed noninvasive DNA based tests to supplant TEM (Christiano and Uitto, 1993).  
Simplex EB is characterized by a disruption within basal keratinocytes immediately 
adjacent to the lamina lucida (Bonifas et al., 1991; Coulombe et al., 1991). This results in 
separation of the upper epidermis from the basement membrane (BM) and leaves an intact BM 
(with a visible lamina lucida and lamina densa) attached to the underlying dermis. Junctional EB 
exhibits a rupture within the lamina lucida leaving the upper separated epidermis intact 
(Christiano and Uitto, 1996). The remaining BM components, specifically the lamina densa 
remain attached to the dermis. The third of the classic types of EB is the dystrophic subtype. This 
subtype is distinguished by a severance within the lamina densa (Christiano et al., 1996). This 
results in a separation of the epidermis from the dermis in which the lamina lucida remains 
attached to the epidermis. The junctional and hemidesmosomal EB subtypes show similar skin 
separation on an ultrastructural level and require further evidence to differentiate between the 
two types(Pulkkinen and Uitto, 1998). 
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Previous work in Belgian horses showed bullous consistent in location and appearance 
with Junctional EB in humans (Johnson et al., 1988). The external pathology of the EI affected 
foals for which samples have been obtained is quite similar to cases identified in the literature as 
EI or EB (Butz and Meyer 1957; Crowell et al., 1976; Dubielzig et al., 1986; Johnson et al., 
1988; Kohn et al., 1989). 
Skin samples from two EI Saddlebred foals and one EI Belgian foal were examined by 
TEM. The results were then compared to TEM images of skin from a normal (non-EI) horse of 
mixed parentage. TEM was used to study the basement membrane and examine the size, number 
and structure of the hemidesmosomes. The results were consistent with a diagnosis of Junctional 
EB. 
 
Materials and Methods 
 
Skin was removed from two euthanized (previously described in Chapter 2) EI 
Saddlebred foals within 2 hours of death. The Belgian skin sample was prepared from frozen (-
20°C) skin obtained one week after necropsy. The samples from the EI affected foals were 
sectioned from the edges of wound lesions on the hindquarters so that the interface between the 
attached epidermis and the exposed dermis could be examined. A skin control sample was 
removed within two hours post mortem from the hindquarters of a Thoroughbred horse that was 
euthanized as part of a separate project. Skin specimens were prepared under the guidance of Pat 
Van Meter.  
Samples were cut to 1 mm cubes and placed in a glutaraldehyde solution for 3 hours. 
Samples were stored in sorensons buffer until use. Samples were then selected for processing in 
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osmium tetraoxide in sorensons buffer for 1 hour. This was followed by two brief washes in 
sorensons buffer. Samples were then dehydrated in increasing concentrations of ethanol.  
 This was followed by 2 immersions in 100% propylene oxide (PO) for 1 hour each. Then 
the samples were immersed in a 50/50 PO/resin mixture for 24 hours under vacuum. The 
samples were placed in 100% resin for 1 hour in shell vials. This was followed by sample 
placement in flat molds in 100% resin for 1 hour, then repeated. The resin was a mixture of Epon 
and Araldite. The samples were lastly placed in flat molds and beam capsules and placed in a 
curing oven at 60°C for 3 days. 
Sections were cut on an ultramicrotome to100nM in thickness. The sections were placed 
on 200 mesh copper grids and stained. The sections were stained in uranyl acetate for 15 min 
followed by three washes in dH2O. The sections were then stained in lead citrate for 15 min 
followed by three washes in dH2O. Sections were then examined via transmission electron 
microscopy on a Hitachi 7000 Electron Microscope in the Gluck Equine Research Center. For 
the full protocol see Appendix i.  
 47 
 
Results 
 
The transmission electron micrographs revealed (a tissue) separation between the 
epidermis and the dermis along the lamina lucida (Figs. 29&30). This separation is consistent 
with the disease pathology of the Herlitz variant of Junctional EB.  
Normal horse skin shows a clear basement membrane with numerous, large, well-
developed  hemidesmosomes (Fig. 27). At higher magnification the hemidesmosomes show the 
characteristic epidermal hemidesmosomal plate, which interacts with the attachment filaments, 
which cross the lamina lucida and in turn bind to the anchoring fibrils that originate in the dermis 
(Fig. 28). Note the distinct basement membrane with a clear lamina lucida, a distinct underlying 
lamina densa and prominent hemidesmosomes.  
  
48 
 
Figure 27. Normal horse skin, epidermis-dermis 
junction. (Micron bar=0.25 µm) 
 
 
 
 
 
 
 
 
Figure 28. Normal horse skin, epidermis-dermis 
junction. (Micron bar=0.10 µm)  
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 In contrast to images of intact skin, micrographes from EI affected foals show 
hemidesmosomes, which occur less frequently, are smaller in size and appear somewhat 
degenerate in appearance (Fig. 29). The interdigitation of the epidermal pegs and the dermal 
papillae appear to be  less complex when compared to normal horse skin (Fig. 30). 
 
 
Figure 29. Skin section from an EI affected 
Saddlebred Foal( 1) (Micron bar=2.0 µm) 
 
 
 
 
 
 
Figure 30. Skin section from an EI affected 
Saddlebred Foal (1) (Micron bar=0.25 µm) 
 
. 
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Figure 31. Bullous split along the basement 
membrane in an EI Saddlebred Foal (1) (Micron 
bar=2.0 µm) 
 
 
Figure 32. Separation between the epidermis 
and dermis. Note that the lamina densa is still 
attached to the dermis and that the basal 
keratinocytes are intact. EI Saddlebred Foal (1) 
(Micron bar=1.0 µm) 
 
 
. 
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Figure 33.  Skin section from an EI Saddlebred 
Foal (2) (Micron bar=1.0 µm) 
 
 
Figure 34.  Note the smaller degenerate 
hemidesmosomes in this skin section from an EI 
Saddlebred Foal (2) (Micron bar=0.5 µm) 
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Figure 35. Dermis side of bullous split with lamina densa still attached. EI Saddlebred 
Foal (2) (Micron bar=1.0 µm)
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Discussion 
 The differences observed in the appearance of hemidesmosomes between normal 
horse skin and skin from EI affected foals suggested that there was a defect within these 
attachment structures in EI affected foals. Such a defect could lead to the bullous 
formation and separation of the epidermis from the underlying dermis, which is observed 
in affected horses (Fig 31). The separation of the skin in EI affected foals is within the 
lamina lucida of the basement membrane. The lamina densa remains attached to the 
dermis and the basal epidermal keratinocytes are intact (Fig 32). This is consistent with a 
laminin 5 defect (Christiano et al., 1996). 
Similar defects were observed in a second American Saddlebred foal affected by 
EI. The intact skin of both EI affected foals shows hemidesmosomes with similar 
degenerate appearances (Fig. 33 & 34). These defective hemidesmosomes lead to the 
split in the lamina lucida and a separation of the epidermis from the dermis as seen in 
Figure 35. Images of skin from Belgian EI affected foals show a comparable separation 
in the skin. 
 The plane of cleavage within the basement membrane of the EI specimens is 
indicative of the subtype of EB and the defective protein. Dystrophic EB is characterized 
by a separation within the dark staining lamina densa leaving the lamina lucida attached 
to the upper epidermis. In humans the lower dermis usually has a rough appearance at the 
site of the bullous (Christiano et al., 1996). The clean separation within the lamina lucida, 
which is seen in the EI affected foals, points to a defect within the anchoring filaments, 
specifically laminin 5. This separation is consistent with a diagnosis of junctional EB. 
 54 
The laminin 5 protein is made up of three subunits. They are the α3, β3 and γ2 
subunits. They form a cruciform shaped protein that binds to the α6β4 integrin in the 
basal epidermal keratinocytes and to the dermal originating collagen VII anchoring 
fibrils. Laminin 5 also plays a role in wound healing by providing an anchor for the α3β1 
integrin which has an important role in cell mobility.  
 In the human lethal Herlitz variant of JEB all mutations identified to date are 
within one of the laminin 5 subunits and result in premature termination codons 
(Christiano and Uitto, 1996). This premature termination codon results in greatly reduced 
levels of mRNA transcripts of the relevant subunit and absence of the protein subunit 
(Christiano and Uitto, 1996). 
 A defective laminin 5 protein would likely result in the degenerate 
hemidesmosomes and bullous formation observed in EI affected foals. In turn this would 
produce the gross pathological signs of broad lesions, dental abnormalities and of poor 
wound healing. These symptoms of equine EI parallel those observed in infants with 
lethal HJEB.  
A defect or lack of one of the α6β4 integrin subunits or BPAG180 could also 
explain the location of the bullous within the lamina lucida observed in the TEM images. 
However, the gross pathological signs fail to implicate any of these proteins as 
pathogenic disease candidates. Mutations in either subunit of the α6β4 integrin can cause 
Hemidesmosomal EB, which is generally accompanied by pyloric atresia and 
comparatively benign skin lesions which appear after birth (Gache et al., 1998; Vidal et 
al., 1995). Necropsy of the two EI affected Saddlebred foals failed to show any 
abnormalities of the intestines or upper digestive tract. Defects in BPAG 180 lead to a 
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non-lethal form of JEB with comparatively mild lesions (Mellerio et al., 1998). The TEM 
images together with the necropsy evidence support laminin 5 as the candidate protein. 
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Chapter Five 
Linkage Disequilibrium 
 
Introduction 
 Analysis of linkage disequilibrium (LD) allows one to measure association of alleles at 
different loci within an entire population. In diploid organisms, recombination occurs during 
meiosis. The two copies of each chromosome pair and their DNA strands physically crossover, 
break and recombine. The chromosomes exchange homologous regions of DNA, thus the two 
resultant chromosomes have the same genes but not necessarily the same alleles as the parental 
chromosome. 
Recombination does not change the linear order of genes. However, it changes the 
original association of alleles on the strand of DNA. According to Hardy-Weinberg equilibrium 
expectations, alleles are associated at random and as products of their phenotypic frequencies in 
the population. When the association of alleles for linked loci is found to be non-random at the 
population level, Hardy-Weinberg equilibrium expectations are not met and the alleles are said to 
exhibit LD. 
Analysis of LD is particularly useful within closed breeding populations for identifying 
allelic association in diseases caused by a single recessive mutation (Risch et al, 1995). For the 
purposes of this study the American Saddlebred and Belgian Draft breeds can be considered 
closed populations. In contrast, the human population is a large, outbred population. 
One example of the difference in variability of a disease gene between humans and 
domesticated animals is malignant hyperthermia (MH). This disease occurs in both humans 
(MH) and pigs (known as porcine stress syndrome). Malignant hyperthermia (MH) is a rapid 
sustained rise in body temperature that can exceed 43°C and lead to death and is induced by 
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the inhalation of volatile anesthetics (Gronert, 1994). In pigs, a single mutation was identified in 
the gene for ryanodine receptor 1 (RYR1). The mutation was a C to T transition mutation, which 
caused a substitution of arginine for cysteine (Fujii et al., 1991). In addition to this mutation the 
disease allele of the RYR1 gene was found to have several silent polymorphisms, coding 
sequence mutations which did not result in amino acid changes (Fujii et al., 1991). These 
polymorphisms were inherited as a single haplotype and strongly suggested that the disease 
mutation arose in a single founder animal. 
 In humans six different mutations in RYR1 have been identified in families with a pre-
disposition for MH (Gillard et al., 1992; Gillard et al., 1991; Keating et al., 1994; Quane et al., 
1993; Quane et al., 1994a; Quane et al., 1994b). The possibility also has been raised that a large 
percentage of MH families may possess different rare mutations in a number of different genes 
(Mickelson et al, 1996). This possibility makes linkage disequilibrium studies much more 
complex in humans because the independent mutation events within the single RYR1 gene make 
it very unlikely that there is a single haplotype associated with MH. 
 A second example is illustrated in Quarter horses where there is evidence that a single 
stallion is the source of the hyperkalemic periodic paralysis (HYPP) susceptibility gene 
(Bowling, 1996). This is a muscular disease characterized by weakness or collapse (Cox, 1985; 
Spier et al., 1990; Steiss and Naylor, 1986). A single C to G mutation in the α-subunit of the 
muscle sodium channel gene causes HYPP in horses(Rudolph et al., 1992). Forty three horses 
were homozygous for this gene out of 978 horses tested (Bowling et al, 1996). All of these 
horses could trace their ancestry back to a single stallion on both sides of the pedigree. 
 More than twenty different mutations have been identified in the human α-subunit of the 
muscle sodium channel gene leading to HYPP (Ptacek, 1997). Some of these mutations are 
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benign polymorphisms (Green et al., 1997). A study of two of the predominant causative 
mutations failed to find a founder affect (Elbaz et al., 1995). Therefore it is possible that at least 
two of the HYPP mutations have appeared independently multiple times. 
 EI in the horse is an autosomal recessive hereditary disease (Butz et al, 1957). In humans, 
the four types of EB each have many causative mutations of different types, which include amino 
acid changes, insertion/deletions and stop codons within the same gene (Anton-Lamprecht, 1995; 
Baudoin et al., 1994; Christiano et al., 1996). The HJEB variant, which is most similar to the 
equine EI, can result from mutations in any of the three genes that code for the subunits of 
laminin 5.  
Genetic heterogeneity may confound studies of inherited diseases, especially in large 
outbred populations. Based on comparison to other genetic diseases in livestock this genetic 
heterogeneity is unlikely to be observed in equine EI within a breed. The partial pedigree 
constructed for American Saddlebred horses suggests that a single founder was responsible for 
the spread of the EI gene in the breed (see Chapter Two). If a single founder were responsible for 
EI in Saddlebreds then one would expect that all of the EI affected Saddlebred horses would 
have the same causative mutation. This genetic homogeneity would be similar to porcine stress 
syndrome in pigs and HYPP in horses. Markers located near the EI locus are more likely to have 
a conserved haplotype through successive generations or meioses since recombination events 
occur less frequently over short lengths of DNA. Unless a recombination creates another 
haplotype with EI all of the EI affected foals should have a similar haplotype. Haplotype 
preservation was observed in Arabians horses with the equine combined immunodeficiency 
locus and the HTG8-186 and HTG8-188 alleles (Bailey et al., 1997). Based upon this expected 
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haplotype conservation, LD analysis can provide a means to identify the laminin 5 subunit in 
which the EI mutation occurs. 
 Three linkage maps have been reported for the horse (Lindgren et al.,1998; Guerin et al., 
1999; Swinburne et al., 2000). In total, more than 400 markers have been tested on the linkage 
maps covering all 31 autosomes and the X chromosome. This low density framework map 
provides the means to test for markers in LD with a disease locus. 
 The morphological and histological evidence indicated that a defect in laminin 5 was the 
best candidate to explain EI. Since laminin 5 contains three different subunits coded by three 
genes LD analysis was used to identify the most likely candidate gene.  
When this study was begun the putative equine chromosome locations of the laminin 5 
subunits were unknown. Subsequently LAM β3 and LAM γ2 were mapped to ECA5 (Mariata, 
2000,Personal Communication; Raudsepp, 2000, Personal Communication). Likewise Human 
chromosome 18, containing LAM α3, has been assigned to ECA8 (Lear 2000, Personal 
Communication). Data from the Horse/Human Comparative Genome Mapping project was used 
to assign putative equine chromosome locations for each of the three laminin 5 subunit genes. 
These were: 
  Gene   Chromosome   Gene  Chromosome 
Human LAM α 3  18q11.2          Equine LAM α3  ECA8 
 Human LAM β 3  1q32               Equine LAM β3  ECA5 
 Human LAM γ 2   1q25-q31        Equine LAM γ2  ECA5 
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Materials and Methods 
Epitheliogenesis Imperfecta Samples 
 Blood and tissue samples from EI affected American Saddlebred (N=10) and Belgian 
Draft (N=6) foals were received from veterinarians and breeders after diagnosis of EI (local 
veterinarians made the diagnosis of EI). Nine of the Saddlebred samples tested are shown in the 
pedigree in Chapter 2 (green numbers 1-9). DNA was extracted from these samples using the 
Puregene DNA isolation kit (Gentra). Concentrations of DNA were determined by taking optical 
density readings using a Spectronic Spectrophotometer (Milton Roy). The DNA samples were 
diluted to a 25ng/ul concentration with Puregene DNA Hydration Solution (Tris 
[hydroxymethyl] aminomethane &EDTA, amounts unlisted). 
Control Samples 
 Sera samples were chosen from a collection of blood samples taken between 1990 and 
2000 for parentage testing. A total of 8 Belgian horse samples and 39 Saddlebred horse samples 
were selected as controls. The Saddlebred samples were chosen so that only one horse came 
from any one farm. Only 8 Belgian horse samples were available as a control group, three of 
which came from 1 farm and 5 from another. The low number of Belgian samples reflected the 
low number of horses of this breed tested for parentage at the University of Kentucky.  
 Two hundred microliters of sera were removed from each tube and heated for 10 minutes 
at 95°C. The heated serum was then spun in a microcentrifuge at the highest speed (~20,000 G) 
for 15 minutes. The resulting supernatant was used as a template in subsequent PCR reactions. 
 Eleven microsatellites markers were selected which mapped to ECA5 and ECA8 as well 
as control markers on ECA2 and ECA30 (Breen et al., 1997; Binns et al., 1995; Coogle et  
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al.,1996a; Coogle et al., 1996b; Godard et al., 1997; Irvin et al., 1998; Lindgren et al., 1999; 
Shiue et al., 1999; Swinburne et al., 2000b; Guerin et al., 1999). These were as follows:  
Table 1. Microsatellites tested and their equine chromosomal location. 
Microsatellite  ASB17   AHT24   HTG15   HTG20   LEX04   ASB14 
Chromosome  ECA2   ECA5     ECA5     ECA5     ECA5    ECA8 
Microsatellite  ASB38   AHT3   HMS18   LEX25    VHL20 
Chromosome  ECA8   ECA8   ECA30   ECA30   ECA30 
Note: The blue microsatellites are hyperlinks to the relevant Ark-db web page and provide 
further pertinent information. 
 
Dye labeled primers based on these markers were produced by Perkin Elmer and used for 
Genescan analysis. The primer sets were placed into multiplexes (based on expected product size 
and fluorescent tag) of several primer sets each. These multiplexes were as follows: (1) LEX25, 
LEX04 and ASB14; (2) VHL20 and AHT3; (3) ASB38, ASB17 and HMS18; (4) AHT24 and 
HTG20. One soloplex consisting of HTG15 was also amplified. 
PCR was performed on template DNA from each of the EI affected and control samples. 
The reaction products were then electrophoresed on a polyacyrlamide gel on an ABI 377 and 
their sizes were measured and analyzed using Genscan and Genotyper software Perkin Elmer 
(Ziegle et al., 1992). For an in-depth protocol see the Appendix i. 
Data analysis 
The gene frequencies were determined for the control populations of Saddlebred and 
Belgian horses by genotyping and direct counting of alleles. Individuals with only one allele 
were assumed to be homozygous. This assumption was supported by the appearance of a 
stronger peak in those individuals. This data was used to determine fit to Hardy-Weinberg 
equilibrium for control and EI populations for both breeds using chi square analysis. P values  
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less than 0.01 were considered significant. This more stringent p value was used because 
multiple loci were being evaluated and in order to decrease the likelihood of falsely rejecting 
Hardy-Weinberg equilibrium by chance. Due to the large number of alleles and the small number 
of individuals in some populations, some phenotypic classes were combined so that all expected 
classes were 1.00 or greater. The number of EI affected Belgian foals and the number of control 
Belgian horse samples was too small for effective statistical analysis for Hardy-Weinberg 
equilibrium. The typing data is presented in Appendix ii and only the phenotypic classes of the 
Belgian horses are presented in this chapter for comparison to the phenotypic classes of EI 
affected Saddlebred horses. 
Results 
 
 Chi square analysis of the Saddlebred horse controls showed that the phenotypic classes 
for all of the microsatellites tested were in Hardy-Weinberg equilibrium (Table 2). Analysis of 
the distribution of alleles for EI affected Saddlebred horses revealed that ASB14 and AHT3, did 
not fit Hardy-Weinberg equilibrium {ASB14, X2=54.014 and p=5.2*10-11; AHT3, X2=59.87 and 
p=4.1*10-12} (Table 2). The allele frequencies of microsatellites for ASB14 and AHT3 for the 
control Saddlebreds are shown in Table 3. Chi square analysis of ASB14 and AHT3 for the EI 
affected Saddlebred horses is presented in greater detail in Tables 4 and 5 respectively. The chi 
square analysis showed that the distribution of alleles for these two microsatellites was out of 
Hardy-Weinberg equilibrium in American Saddlebred horses. The groups column denotes by 
number how the alleles were pooled, a – indicates that the respective allele was not pooled.  
Tables 6  and 7 show the genotypes for AHT3 and ASB14 for each of the EI affected foals, 
Saddlebred horses and Belgian horses respectively. For AHT3, all Saddlebred foals were 
homozygous for allele 141 while this allele did not occur among Belgian foals. Indeed, the 
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Belgian foals possessed 3 different alleles and only 2 out of 6 were homozygous. For ASB14 the 
Saddlebred foals possessed predominantly allele 113; 8 of 10 foals were homozygous for this 
allele while two foals had the 113/121 phenotype. Again the 6 Belgian foals had more 
heterogeneous phenotypes, however allele 113 did predominate. 
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Table 2. Summary of Chi square analyses of Hardy Weinberg Equilibrium (HWE) of 
microsatellites tested in Saddlebred horses 
 
  Control Population (N=34) Affected Population (N=10) 
Microsatellite Chromosome X2 HWE P HWE X2 HWE P HWE 
AHT24 ECA5 0.068 0.794 5.87 0.015         
HTG15 ECA5 3.409 0.492 5.35 0.294 
HTG20 ECA5 6.823 0.234 3.60 0.608 
LEX04 ECA5 4.157 0.527 6.75 0.24 
ASB14 ECA8 5.829 0.212 54.014 5.2*10-11  *** 
AHT3 ECA8 3.409 0.492 59.87 4.1*10-12  *** 
ASB38 ECA8 4.069 0.54 4.107 0.534 
ASB17 ECA2 20.137 0.065 4.61 0.97 
HMS18 ECA30 7.325 0.062 6.31 0.097 
LEX25 ECA30 4.615 0.465 7.00 0.220 
VHL20 ECA30 11.28 0.08 7.53 0.274 
Note: *** indicates P<0.001 
 
 
 
 
 
Table 3. Gene Frequencies for ASB14 and AHT3 in the  
Control Saddlebred horse population 
 
ASB14 N=30 Frequency AHT3 N=34 Frequency 
125 0.38 141 0.32 
121 0.33 139 0.04 
119 0.12 137 0.16 
115 0.05 135 0.01 
113 0.12 133 0.03 
  131 0.00 
  129 0.26 
  127 0.16 
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Table 4. Genotypic Classes and Chi square analysis of Hardy  
Weinberg Equilibrium (HWE) for ASB14 in the EI affected Saddlebred foals 
 
   Observed Expected  
Microsat Allele 1 Allele2 Aff Ct Aff exp Groups 
ASB14 113 113 8 0.1 2 
ASB14 113 119 0 0.3 3 
ASB14 113 121 2 0.8 1 
ASB14 113 125 0 0.9 2 
ASB14 115 115 0 0.03 1 
ASB14 115 125 0 0.4 1 
ASB14 119 119 0 0.1 3 
ASB14 119 121 0 0.8 3 
ASB14 121 121 0 1.1 - 
ASB14 121 125 0 2.6 - 
ASB14 125 125 0 1.5 - 
Chi-Squared value= 54.01 
p value= 5.2*10-11 
 
 
 
Table 5. Genotypic Classes and Chi square analysis of Hardy  
Weinberg Equilibrium (HWE) for AHT3 in the EI affected Saddlebred foals 
 
   Observe Expected  
Microsat Allele 1 Allele2 Aff Ct Aff exp Groups 
AHT3 127 127 0 0.236 4 
AHT3 127 137 0 0.471 5 
AHT3 127 139 0 0.128 4 
AHT3 127 141 0 0.942 1 
AHT3 129 129 0 0.631 5 
AHT3 129 137 0 0.771 4 
AHT3 129 141 0 1.542 - 
AHT3 133 137 0 0.086 1 
AHT3 133 141 0 0.171 3 
AHT3 135 139 0 0.012 1 
AHT3 137 139 0 0.128 2 
AHT3 137 141 0 0.942 2 
AHT3 141 141 9 0.942 3 
Chi-Squared value=65.124 
p value= 4.07*10-12 
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Table 6. Genotypes for ASB14 and AHT3 among EI affected Saddlebred horses 
 
    ECA8   ECA8    
Inventory # Pedigree # ASB14 1 ASB14 2 AHT3 1 AHT3 2 
EI01 4 113 113 NA1 NA1 
EI04 5 113 113 141 141 
EI05 8 113 113 141 141 
EI10 - 113 113 141 141 
EI13 2 113 113 141 141 
EI15 9 113 113 141 141 
EI16 6 113 121 141 141 
EI20 3 113 113 141 141 
EI21 7 113 113 141 141 
EI24 1 113 121 141 141 
1NA= Results are not available for this particular microsatellite.  
Note: Pedigree numbers correspond to the green numbers in the pedigree in Chapter Two 
 
 
 
 
 
 
 
 
Table 7. Genotypes for ASB14 and AHT3 among EI affected Belgian horses 
 
  ECA8   ECA8    
 ASB14 1 ASB14 2 AHT3 1 AHT3 2 
EI003 113 113 135 135 
EI012 113 113 129 135 
EI17 113 121 135 135 
EI018 113 121 129 139 
EI019 113 113 129 135 
EI023 121 125 135 139 
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Discussion 
 
 Morphological analysis and histological studies led to the hypothesis that a defect in one 
of the three laminin 5 subunits was responsible for EI. Comparative map studies indicated that 
homologues of the human laminin 5 subunits were located on ECA5 and ECA8. Therefore the 
genotypic distributions of microsatellites located on ECA5 and ECA8 were studied in normal 
horses and those affected by EI. The genotypic distributions of the microsatellites fit Hardy-
Weinberg equilibrium in the control population. Even though only 10 American Saddlebred EI 
affected foals were studied, the genotypic distributions of ECA5 microsatellites fit Hardy-
Weinberg equilibrium (Table 2). However, when these same EI affected foals were tested for fit 
to Hardy-Weinberg equilibrium with microsatellites on ECA8 it was found that ASB14 and 
AHT3 were not in Hardy-Weinberg equilibrium (ASB14, X2=54.014 and p=5.2*10-11; AHT3, 
X2=59.87 and p=4.1*10-12). 
 The Saddlebred AHT3-141 allele had a frequency of 0.32 in the normal population and 
1.00 in the affected population (Tables 2). Chi square analysis of the Saddlebred EI AHT3 
observed values compared to the Hardy-Weinberg expected values calculate a p value of 
4.07*10-12 (Table 5). This indicates that the EI affected Saddlebreds are not in Hardy-Weinberg 
equilibrium at AHT3. All of the Saddlebred EI affected foals are homozygous for AHT3-141, 
which fits expectations of LD for markers near the EI locus. 
The Saddlebred ASB14-113 allele had a frequency of 0.12 and ASB14-121 allele had a 
frequency of 0.33 in the normal population and 0.9 and 0.1, respectively, in the affected 
population (Table 3). Chi square analysis of the Saddlebred EI ASB14 observed values compared 
to the Hardy-Weinberg expected values calculate a p value of 5.2*10-11 (Table 4). This indicates 
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that the affected Saddlebreds are not in Hardy-Weinberg equilibrium at ASB14. The evidence 
shows that ASB14 is in LD with AHT3 and the EI disease locus. 
Linkage mapping of ASB14 and AHT3 on ECA8 suggested that they were located close 
together (Swinburne et al., 2000a). One would predict that if LD was observed between one of 
the markers and the EI disease locus it should be seen at the other. Both of the alleles should be 
in phase for the majority of EI affected foals tested if they are both in LD with the EI disease 
locus. 
Analysis of ASB14-113 and AHT3-141 alleles, in Saddlebred horses indicated that both of 
these microsatellite loci are in LD with the EI disease locus. The ASB14-113 and AHT3-141 
alleles are in phase in 7 out of 9 EI Saddlebred foals tested (Table 6). This suggested that the 
mutation responsible for EI occurred creating a haplotype of ASB14-113, AHT3-141 and EI. Two 
foals ( EI 24 and EI 16) were heterozygous for ASB14 113 and 121. This suggested that 
sometime in the past a recombination event occurred between ASB14 and both AHT3 and the EI 
disease locus. This event changed the ASB14 haplotype associated with EI from 113 to 121. This 
indicates that AHT3 is located more closely to the EI disease locus than ASB14. Both AHT3 and 
ASB14 are located on ECA8, the putative location of LAM α3 (Swinburne et al., 2000a, Lear, 
personal communication). This supports LAM α3 as the EI disease locus in Saddlebred horses.  
The homogeneity of phenotypes at AHT3 and ASB14 observed in EI affected Saddlebred 
horses was not reflected in the EI affected Belgian horses (Table 7). The predominant allele at 
ASB14 in the EI affected Belgian horses was 113. Three heterozygotes were observed for three 
different alleles. This heterogeneity does not support LAM α3 as the EI disease locus in Belgian 
horses. 
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The differences between the observed phenotypes at ASB14 and AHT3 in EI affected 
Saddlebred horses and EI affected Belgian horses have two possible explanations. First, it is 
possible that the EI affected Saddlebred horses and Belgian horses both share the same mutation 
for EI but that the mutation was introduced much earlier in Belgian horses. If this was the case 
then the longer period of time and greater number of meiotic events would increase the 
probability that recombination would change the original EI haplotype in Belgian horses. This 
would make it unlikely that signs of LD would be detected with the sample sizes used in this 
study.  
 Second it is possible that the EI mutation in Belgian horses occurred 
independently from that in Saddlebred horses. If this was the case, the mutation could be in a 
different site within the same subunit or within the gene for one of the other two subunits. All 
three subunits in laminin 5 can produce identical disease pathology in humans. It is possible that 
a defect in either LAM γ2 or LAM β3 could result in EI in Belgians. While not trivial, 
sequencing of LAM α3 in the American Saddlebred horse and comparing it to the sequence of 
LAM α3 in Belgian horses would clarify the situation. 
The LD analysis of the American Saddlebred results supported the LAM α3 subunit as 
the EI disease locus. Analysis of the Belgian results did not provide evidence supporting any of 
the laminin 5 subunits as the EI disease locus. 
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Chapter Six 
cDNA Library Construction and Characterization 
 
Introduction 
Interest in identifying the sequence of the laminin 5 subunits provided the impetus to 
build a horse skin cDNA library. cDNA libraries are useful for providing relevant clones that are 
shorter and easier to sequence because the clones lack introns. The coding sequence of genes in 
eukaryotic genomic DNA is usually made up of a series of exons (coding DNA) interspersed 
with introns (noncoding DNA). cDNA is produced from mRNA transcripts in which the introns 
have been spliced out. This results in a shorter length of nucleotides which represents the code 
for that respective protein. For example, in humans the genomic sequence of Collagen VII is ~32 
kb in length and consists of 118 exons, the most exons in a gene identified to date (Christiano et 
al., 1994). In contrast the Collagen VII mRNA transcript is ~8.9kb in length. The primary tissue 
in which laminin 5 is expressed is the skin (Masunaga et al., 1996). In the skin, keratinocytes 
produce laminin 5 (Rousselle et al., 1991). Laminin 5 also has been found to be expressed in the 
tooth and the intestine, however the cDNA library was built from skin since all of the proteins 
potentially responsible for EI are known to be expressed there (Orian-Rousseau et al., 1996; 
Mullen et al., 1999). While this made tissue collection relatively easy there were some 
drawbacks.  
The quality of a cDNA library is dependent on the quantity and length of the mRNA used 
to build the library. Both of these attributes suffer when isolating mRNA from skin. Skin 
contains a great deal of extracellular matrix protein, which reduces the amount of total RNA 
extracted per gram of starting tissue and makes the skin difficult to homogenize (Hipfel et al., 
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1998). Skin also secretes RNAases from the sebaceous glands as part of the primary immune 
defenses (Dobbeling et al., 1997). These attributes make skin a problematic but not impossible 
source of mRNA. 
The results of this study will be published in Animal Biotechnology (Lieto and Cothran, 
in press).  
 
Materials & Methods 
 Horse skin was harvested immediately post-mortem and flash frozen in liquid nitrogen. 
The skin was acquired from a four year old female Thoroughbred horse euthanized as part of 
another study. Total RNA was extracted from the horse skin using Qiagen’s Maxi-spin protocol 
and columns. Messenger RNA was purified from the total RNA using Stratagene’s Poly A Quick 
mRNA isolation kit. The presence of mRNA was verified via electrophoresis on a 1% agarose 
gel with ethidium bromide visualization on an ultraviolet light box.  
 A directional cDNA library was constructed from the mRNA using Stratagene’s Zap 
Express XR Library Kit following standard protocols. The library was oligo dt primed and the 
inserts were constructed with a 5’ Eco R1 site and a 3’ Xho 1 site. The library was directionally 
ligated into XL-1 Blue MRF Strain E. coli and plated out on NZY agar. Random plaques were 
picked and the insert was PCR amplified. The PCR product was electrophoresied on an agarose 
gel and the resulting single band was cut and purified using Qiagen’s gel purification protocol 
and columns. The Purified product was then labeled with Big Dye Terminators following Perkin 
Elmer’s Protocol and sequenced on an ABI 377 (Perkin Elmer). For examples see Smith et al. 
(1986) and Kaiser et al. (1989). For an in depth protocol see Appendix i. 
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EST Characterization 
 Similarity searches were performed on the obtained sequences through NCBI’s BLAST 
search using the blastn search on the non-redundant database with the filter set to default. A 
match was considered significant if a similarity greater than or equal to 75% was returned for a 
continuous overlapping region of at least 70bp. Alignments of ESTs from the same gene were 
performed using the software package Gentools (Biotools Inc., Edmonton Canada). 
 Three hundred and thirteen sequences were submitted to Genbank’s dbEST database and 
currently are available on-line. 
 
Library Screening 
 The library was screened with a DNA probe. The probe was PCR amplified from equine 
DNA using primers developed from human LAM γ 2 exon 9, Genbank accession number 
U31186.1. The probe was sequenced to verify that it represented sequence from equine LAM γ2 
exon 9. The horse LAM γ2 probe sequence was : 
5’TTAAAACCCCCTCCCGTTTCCGGAGCCCCAGCGCCCTGGGTTGAACAATGTGTATGCCCTGTT
GGCTACAAGGGGCAGTTCTGCCAGGATTGTGCTTCCGGCTACAAAAGAGATTCAGCCAGACTGG
GACCTTTTGGCACCTGTATTCCATGTAACTGTCAAGGGGGAGGGG 3’ 
. The probe was sequence verified before labeling. Three labeling procedures were used 
with this probe. These were Amersham’s ECL 3’ oligolabeling, Boerhinger Mannheim’s DIG 
labeling and P32 labeled dCTP incorporation. Examples of these procedures are described by 
Seibl et al. (1990), Yu et al. (1995) and Benton et al. (1977). These labeled probes were screened 
against the library and detected with their relevant detection kits. See Appendix i for further 
detail. 
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Results 
EST Characterization 
 
The expression library had 5.8X 105 plaque forming units with 99% recombinant phage 
before amplification. The average insert size was 1.3X 103 base pairs. Three hundred and eighty 
clones were single pass sequenced from their five prime ends. These 380 clones provided 313 
useful EST sequences with an average length of 450 bp. Of the 313 ESTs, 207 were putatively 
identified (66%) as matching a nucleotide sequence in the Genbank database (Table 8). The 
class in which the putatively identified sequences most commonly fell was that of translational 
proteins (26%). Transcription, translation, cell cycle and mitochondrial proteins make up 40% of 
the identified ESTs (Fig. 36). Proteins involved in immune responses (5%) were also found. This 
is to be expected when we consider that the skin plays host to many cells such as macrophages 
and T cells which produce mRNA. 
There were two contaminating ribosomal RNAs; they both were identified as the 
ribosomal 18s RNA gene. This indicates that the library is contaminated with ribosomal RNA at 
a level around 0.006%. Further characterization of the library will provide more information on 
the frequency of the observed number of ribosomal RNAs. 
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Figure 36 
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Figure. 37 
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Library Screening 
Screening the library with the equine LAM γ2 probe identified seven clones with 
hybridization homology with the LAM γ2 transcript. The primers that amplified the LAM γ2, 
exon 9 from genomic DNA successfully amplified a similar size product from an aliquot of the 
cDNA library. This product was sequenced and was found to be identical to the known probe 
sequence. 
The seven clones which were isolated had inserts of near identical size, about 900 bp in 
length. However, sequencing the 5’ ends of these inserts revealed that they all had a putative 
homology with phosphatidylinositol-4-phosphate 5-kinase isoform C (PPK). Clustal alignments 
performed between the sequence of the probe (LAM γ2, exon 9) and the sequence of these inserts 
revealed regions of limited sequence homology.  
 
Discussion 
EST Characterization 
These ESTs represent the first identified and publicly available ESTs in the horse. The 
putatively identified ESTs fit categories that would be expected to exist in a tissue such as the 
skin. Overall the ESTs identified paint a picture of a tissue in a state of constant renewal, 
producing a plethora of proteins involved in functions such as structural integrity, signaling and 
pigment production. This is consistent with the kinds of gene expression we would expect to 
observe in a tissue such as skin. 
The identified ESTs most frequently matched human genes (Table 8) in the Genbank 
database. This is to be expected considering that more human gene sequence is available than for 
any other species. The remaining ESTs matched other mammalian sequences except for 
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EQUK466 which shared the highest homology with the feline leukemia virus (FeLV) sequence 
for Notch2. The Notch2 protein is a mammalian transmembrane receptor; its sequence was found 
to be present in experimental recombinant FeLV (Rohn, 1996). Since FeLV is a retrovirus the 
presence of Notch2 in the FeLV genome can be accounted for by its ability to splice a host’s 
transcript into its genome. 
Twenty three percent of the putatively identified ESTs were redundant. These redundant 
ESTs occurred in five functional groups (Fig. 37). The most frequently represented transcript 
identified was that for Stearoyl-CoA desaturase, a protein involved in fatty-acid metabolism. 
Since we used the whole skin to prepare our library this coincides with the high adipocyte 
concentration of the hypodermis. The seven ESTs putatively identified as Stearoyl-CoA 
desaturase form a continuous contig spanning 1250 base pairs. However this represents only 
25% of the human Stearoyl-CoA desaturase cDNA. 
EST sequences homologous to Collagen III, Collagen I and several Keratins were 
putatively identified (Fig. 37). One of the Keratins putatively identified was Keratin 14 which 
when defective in humans leads to Epidermolysis Bullosa Simplex. 
Library Screening 
The library was subsequently screened using a labeled horse probe amplified from equine 
LAM γ2, exon 9. A variety of labeling methods, including DIG, Flourescein and P32 were used 
as well as a plethora of different stringency conditions. The primers used to amplify the LAM γ2 
probe from equine DNA also amplified a similar size and sequence product from the cDNA 
library. However a positive clone representing the LAM γ2 transcript was not isolated. 
The likely reason for this was sequence homology between the probe and other 
transcripts. This would have led to the isolation of seven separate positive clones which all had 
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inserts for PPK. Development of another probe based on another LAM γ2 exon or a labeled 
antibody specific for the LAM γ2 protein would be useful for avoiding the non-specific binding 
of the exon 9 probe. Further efforts developing probes from human gene homologues for the 
LAM α3 and the LAM β3 subunits would be useful for isolating clones for these subunits from 
the cDNA library. 
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  Table 8. Equus caballus skin ESTs identified by database search 
Class1 Clone2 Putative Identification3 Species4 I.D.5 %6 Ace. Number7 
Apoptosis EQUK52 Death Effector Domain Factor Homo sapiens 618/672 91% AF179286 
 EQUK184 Signal Recognition SRP72 Homo sapiens 116/123 94% NM_006947.1 
 EQUK356 Programmed Cell Death 5 (TFAR19) Homo sapiens 288/317 90% NM_004708.1 
       
Cell Cycle EQUK66 Cyclin G1 Homo sapiens 97/110 88% U47413 
 EQUK126 Cell Division Cycle 10 CDC10 Homo sapiens 129/159 81% NM_001788.1 
 EQUK324 Cyclin B Homo sapiens 535/575 93% M25753 
 EQUK434 Calcyclin  Equus caballus 387/395 97% AF083065 
 EQUK453 Calcyclin  Equus caballus 422/425 99% AF083065 
 EQUK465 Ligase III Homo sapiens 185/220 84% NM_002311.1 
       
Cell surface EQUK60 Poliovirus Receptor-like 2 Homo sapiens 290/336 86% NM_002856.1 
       
Coat color EQUK55 Tyrosinase Related Protein 1 Homo sapiens 315/390 80% NM_000550.1 
 EQUK160 Attractin-2 Homo sapiens 449/507 88% AF106861 
       
Development EQUK162 Mago-nashi Homo sapiens 158/173 91% NM_002370.2 
       
Immune EQUK85 B-cell Associated Protein Homo sapiens 375/426 88% NM_007273 
 EQUK75 Calgranulin B Ory. cuniculus 210/256 82% AF091849 
 EQUK64 Thymosin Beta 4 Homo sapiens 447/507 88% M17733.1 
 EQUK101 Thymosin Beta 4 Mus musculus 535/569 94% X16053 
 EQUK480 Squamous Cell Carcinoma Antigen  Homo sapiens 394/429 91% AF098066.1 
 EQUK471 Equ c1  Equus caballus 403/445 90% U70823 
 EQUK450 Equ c1  Equus cabalus 270/296 91% U70823 
 EQUK445 T-cell receptor alpha delta  Homo sapiens 121/142 85% AE000659 
 EQUK443 MHC II DMB Homo sapiens 157/182 86% NM_002118.1 
 EQUK316 Equ c1 Equus caballus 555/598 92% U70823 
 EQUK258 Galectin 3 Homo sapiens 256/282 90% AB006780 
 EQUK232 Thymosin Beta 4 Homo sapiens 265/300 88% M17733 
 EQUK258 Galectin 3 Homo sapiens 256/282 90% AB006780 
       
Kinase/ EQUK95 Tyrosine Phosphatase Homo sapiens 85/104 81% NM_005401 
Phosphatase EQUK128 Acylphosphatase 2 Homo sapiens 178/199 89% NM_001108.1 
 EQUK142 Mitogen Activated protein Kinase 6  Homo sapiens 448/478 93% NM_002748.1 
 EQUK165 Pyruvate dehydrogenase kinase PDK1 Homo sapiens 106/128 82% HUMPDK1R 
 EQUK283 14-3-3 protein Beta Bos taurus 283/314 90% AF043736 
 EQUK311 Tyrosine Kinase JAK1 Homo sapiens 134/152 88% AF052689 
 EQUK426.1 YAP65  Homo sapiens 272/280 97% X80507 
 EQUK394 Phosphatase 1 subunit 7 Homo sapiens 369/420 87% NM_002712.1 
       
Metabolism EQUK104 Calmodulin-stimulated 
Phosphodiesterase 
Homo sapiens 131/145 90% U86078 
 EQUK117 Isopentenyl-diphosphate delta 
isomerase  
Homo sapiens 221/249 88% NM_004508 
 EQUK121 Stearoyl-CoA Desaturase Homo sapiens 210/226 92% AF097514.1 
 EQUK159 Stearoyl-CoA Desaturase Homo sapiens 176/219 80% AF097514.1 
 EQUK208 Isocitrate Dehydrogenase 3 alpha Homo sapiens 288/335 85% NM_005530.1 
 EQUK230 CU/ZN Superoxide Dismutase Equus caballus 384/391 98% AB001692.1 
 EQUK236 Glutamate Dehydrogenase Homo sapiens 253/282 89% U08997 
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 EQUK268 Stearoyl-CoA Desaturase Homo sapiens 72/77 93% AF097514.1 
 EQUK295 Endozepine Sus scrofa 300/334 89% AB019792 
 EQUK335 Endozepine Sus scrofa 193/216 89% AB019792 
 EQUK351 Calmodulin 1  Homo sapiens 224/244 91% NM_006888.1 
 EQUK361 Niemann-Pick disease protein C1 Homo sapiens 205/236 86% NM_000271.1 
 EQUK366 Stearoyl-CoA Desaturase Homo sapiens 313/391 80% AF097514.1 
 EQUK375 Regucalcin Homo sapiens 180/215 83% AB032064.1 
 EQUK405 Cell growth regulating protein Homo sapiens 110/125 88% L10844 
 EQUK424 B-myb Homo sapiens 479/553 86% NM_002466.1 
 EQUK425 Stearoyl-CoA Desaturase  Homo sapiens 440/508 86% AF097514.1 
 EQUK458 Glycogenin Homo sapiens 218/253 86% X79537 
 EQUK464 Calmodulin Homo sapiens 389/412 94% D45887 
 EQUK481 Stearoyl-CoA Desaturase  Homo sapiens 336/391 85% AF097514.1 
 EQUK484 Stearoyl-CoA Desaturase  Homo sapiens 328/415 79% AF097514.1 
       
Mitochondrial EQUK167 Mitochondrial DNA Equus caballus 329/339 97% NC_001640.1 
 EQUK289 Cytochrome B Equus caballus 697/736 94% D32190 
 EQUK337 Mitochondrial DNA Equus caballus 263/281 93% NC_001640.1 
 EQUK378 Mitochondrial DNA  Equus caballus 407/432 94% NC_001640.1 
 EQUK462 Mitochondrial DNA  Equus caballus 399/413 96% NC_001640.1 
 EQUK479 Mitochondrial DNA Equus caballus 213/232 91% NC_001640.1 
 EQUK482 Mitochondrial DNA Equus caballus 407/419 97% NC_001640.1 
 EQUK483 Mitochondrial DNA Equus caballus 763/806 94% NC_001640.1 
 EQUK485 Mitochondrial DNA  Equus caballus 740/776 95% NC_001640.1 
 EQUK488 Mitochondrial DNA  Equus caballus 232/236 98% NC_001640.1 
       
Nuclear EQUK255 Nucleolar Phosphoprotein B23 Homo sapiens 245/261 93% M28699 
 EQUK346 H3 Histone 3B Homo sapiens 182/200 91% NM_005324.1 
       
Nuclear EQUK223 Mit-ATP synthase P1 subunit Bos taurus 269/287 93% X05218 
Mitochondrial EQUK275 Mitochondrial matrix protein  Homo sapiens 87/95 91% M22382 
 EQUK379 Enoyl Coenzyme A Hydratase 1 Homo sapiens 167/199 83% NM_001398.1 
 EQUK430 Coenzyme A Hydratase  Homo sapiens 334/379 88% NM_001698.1 
       
Protease EQUK51 Proteasome PSMA2 Homo sapiens 80/97 82% NM_002787.1 
 EQUK59 Serine Proteinase Homo sapiens 102/122 83% NM_006846.1 
 EQUK115 Endopeptidase 24.16 Sus scrofa 193/202 95% AB00041S15 
 EQUK133 Proteasome PSMB5 Homo sapiens 240/286 83% NM_002797.1 
 EQUK215 Serine Protease 19 neuropsin/ovasin Homo sapiens 135/163 82% NM_007196.1 
 EQUK369 Cathepsin S, cysteine proteinase  Homo sapiens 300/348 86% S39127 
       
Protein-Protein EQUK87 Ubiquitin Protein Ligase Mus musculus 167/189 88% AF037454 
 Interaction EQUK325 Int-6  Homo sapiens 498/555 98% U85947 
 EQUK358 Cyclophilin (CYP-20)  Homo sapiens 402/427 94% AF036331 
       
Signaling EQUK49 Ran-GTP Binding Protein Homo sapiens 452/509 88% AF039023 
 EQUK61 Grb7V Protein Homo sapiens 454/561 80% AB008790 
 EQUK466 Notch2  Feline leukemia 
virus 
256/279 91% U47644 
       
Structure EQUK48 Keratin 14 Homo sapiens 504/562 89% NM_000526.1 
 EQUK71 Keratin 1 Homo sapiens 100/115 86% M98776 
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 EQUK76 Loricrin  Homo sapiens 265/325 81% NM_00427.1 
 EQUK77 FAT Tumor suppressor Homo sapiens 321/359 89% NM_005245.1 
 EQUK118 Cytokeratin 10 acidic Type 1 Homo sapiens 97/107 90% X14487 
 EQUK119 Colin Carcinoma Laminin-Binding 
Protein 
Homo sapiens 549/609 90% J03799 
 EQUK148 Collagen III Alpha 1 Homo sapiens 171/193 88% NM_000090.1 
 EQUK154 High-Sulfur Keratin BIIIB4 Ovis aries 171/196 87% M21103 
 EQUK155 T-Plastin Homo sapiens 427/492 86% L05491 
 EQUK183 Plastin 3 PLS3 Homo sapiens 250/264 94% NM_005032.1 
 EQUK224 Collagen III Homo sapiens 309/340 90% NM_000090.1 
 EQUK227 Beta Actin  Canis familiaris 297/325 91% AF021873.2 
 EQUK257 Matrilin 2 Homo sapiens 327/376 86% U69263 
 EQUK326 Apha-tubulin Macaca 
fascicularis  
547/604 90% X04757 
 EQUK342 Collagen Type 1 Alpha 2 Homo sapiens 366/401 91% NM_000089.1 
 EQUK391 Laminin Receptor Homolog  Homo sapiens 420/469 89% S35960 
 EQUK406 p0071 protein Homo sapiens 103/116 88% X81889 
 EQUK426 Loricrin  Homo sapiens 122/139 87% M94077 
 EQUK433 Dynein light chain 1  Homo sapiens 362/426 84% NM_003746.1 
 EQUK463 Procollagen Type 1 COL1A2 Canis familiaris 160/181 88% AF035120 
 EQUK470 Collagen  Type III COL3A1 Homo sapiens 236/274 86% NM_000090.1 
 EQUK472 BIIIB2 High-Sulfur Keratin  Ovis aries 301/359 83% M21099 
       
Transcription EQUK84 High Mobility Group 1 Protein Bos taurus 465/495 93% X12796 
 EQUK146 P35sj  (MRG1) Homo sapiens 326/352 92% AF109161 
 EQUK164 Neural specific sr protein Mus musculus 126/141 89% AB015895 
 EQUK181 Protein Synthesis Elongation Factor  
Tu Alpha  
Mus musculus 172/198 86% M22432 
 EQUK194 Zinc Finger Transcription ProteinGKLF Homo sapiens 467/517 90% AF105036.1 
 EQUK221 Chaperonin protein TCP1 subunit 7 Homo sapiens 227/263 86% NM_006429.1 
 EQUK276 Ubiquinol-cytochrome C reductase 
binding protein 
Homo sapiens 190/213 89% NM_006284.1 
 EQUK278 Basic Transcription Factor 3b Homo sapiens 266/301 88% X53281 
 EQUK297 Zinc Finger Protein 9 Homo sapiens 467/503 92% NM_003418.1 
 EQUK315 c-myc transcription factor Homo sapiens 89/91 98% L16785 
 EQUK339 Nucleolin Homo sapiens 174/190 91% NM_005381.1 
 EQUK370 nuclear ribonucleoprotein D-like Homo sapiens 458/483 94% NM_005463.1 
 EQUK376 Nuclear Factor like 2 (NFE2L2)  Homo sapiens 245/284 86% NM_006164.1 
 EQUK403 ZBP-89 protein Homo sapiens 366/395 92% AJ236885.1 
       
Translation EQUK1 Ribosomal Protein RPLP1 Homo sapiens 290/312 92% NM_001003.1 
 EQUK2 Ribosomal Protein L3 Homo sapiens 404/440 91% NM_000967 
 EQUK4 Ribosomal Protein S18 Homo sapiens 394/418 94% X69150 
 EQUK5 Elongation Factor 1 alpha Bos taurus 361/395 91% AF013213 
 EQUK9 Ribosomal Protein L31 Homo sapiens 347/376 92% X69181 
 EQUK50 Ribonucleoprotein A1 Homo sapiens 330/356 92% NM_002136.1 
 EQUK57 Ribosomal Protein S12 Sus scrofa 394/430 91% X79417 
 EQUK62 Elongation Factor 1-Alpha Ory. cuniculus 232/245 94% U09823 
 EQUK70 Elongation Factor 1 Alpha Bos taurus 430/486 88% AF013213 
 EQUK73 Ribosomal Protein RPLPO Homo sapiens 451/478 94% NM_001002.1 
 EQUK78 Ribosomal Protein L3 Bos taurus 358/405 88% Z29555 
 EQUK90 Ribosomal Protein L35 Homo sapiens 355/397 89% NM_007209 
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 EQUK135 Ribosomal L4 Canis 408/455 89% X99909 
 EQUK139 Ribosomal Protein S11 Homo sapiens 357/391 91% NM_001015.1 
 EQUK147 Ribosomal Protein L4 Rattus  norvegicus 234/269 86% X82180 
 EQUK151 Ribosomal Protein L15 Homo sapiens 572/641 89% NM_002948.1 
 EQUK163 Ribosomal S19 Homo sapiens 232/253 91% NM_001022.1 
 EQUK177 Ribosomal L17 Homo sapiens 99/113 87% NM_000985.1 
 EQUK205 Ribosomal Protein L31 Homo sapiens 360/388 92% NM_000993.1 
 EQUK211 Ribosomal protein S3a Homo sapiens 112/130 86% M77234 
 EQUK213 Ribosomal Protein L9 Homo sapiens 516/568 90% U21138 
 EQUK219 Ribosomal Protein S6 Chlor.aethiops 247/265 93% AJ249383.2 
 EQUK234 Ribosomal protein L3 Bos taurus 410/471 87% Z29555.2 
 EQUK247 Ribosomal L7A Homo sapiens 232/264 87% NM_00972.1 
 EQUK293 Ribosomal Protein S25 Homo sapiens 409/444 92% NM_001028.1 
 EQUK303 Ribosomal protein L17 Homo sapiens 504/569 88% NM_000985.1 
 EQUK308 Ribosomal Protein S23 Homo sapiens 428/485 88% NM_001025.1 
 EQUK323 Ribosomal protein L3 Bos taurus 424/482 87% Z29555.2 
 EQUK354 Ribosomal protein S6  Homo sapiens 395/441 90% NM_001010.1 
 EQUK365 Ribosomal protein L41  Felis domesticus 203/246 82% U22229 
 EQUK367 Translation Initiation factor nuk 34  Homo sapiens 410/460 89% X79538 
 EQUK372 Ribosomal protein S10  Homo sapiens 440/497 88% NM_001014.1 
 EQUK377 Ribosomal protein S23  Homo sapiens 318/362 87% NM_001025.1 
 EQUK381 Ribosomal protein S24  Homo sapiens 199/230 86% NM_001026.1 
 EQUK382 Ribosomal protein L31  Homo sapiens 313/344 90% NM_000993.1 
 EQUK386 Ribosomal protein L32  Homo sapiens 364/392 92% NM_000994.1 
 EQUK396 Ribosomal protein (RPLPO) Homo sapiens 537/587 91% NM_001002.1 
 EQUK412 Ribosomal protein S6  Homo sapiens 582/637 91% NM_001010.1 
 EQUK414 Ribosomal protein L14 Homo sapiens 88/99 88% NM_003973.1 
 EQUK418 Ribosomal protein L35a  Homo sapiens 271/304 89% X05705 
 EQUK423 Ribosomal protein S4 Equus caballus 568/582 97% D50109 
 EQUK432 Ribosomal protein S25  Homo sapiens 309/332 93% NM_001028.1 
 EQUK442 Ribosomal protein S8 Homo sapiens 128/151 84% X06423 
 EQUK444 RNA binding protein FMRIP  Homo sapiens 329/380 86% AF159548.1 
 EQUK448 Ribosomal protein S8 Rattus norvegicus 223/245 91% X06423 
 EQUK449 Ribosomal protein S3a  Felis domesticus 258/287 89% U22231 
 EQUK460 Nuclear Ribonucleoprotein C Homo sapiens 434/458 94% NM_004500.1 
 EQUK468 Ribosomal protein L12  Homo sapiens 398/436 91% NM_000976.1 
 EQUK473 Ribosomal protein RPLPO Homo sapiens 449/481 93% NM_001002.1 
 EQUK476 Ribosomal protein S6  Homo sapiens 420/473 88% NM_001010.1 
 EQUK486 Ribosomal protein RPLPO Homo sapiens 494/538 91% NM_001010.1 
 EQUK487 Ribosomal protein S6 Homo sapiens 507/569 89% NM_001010.1 
       
Transport EQUK7 Thiosulfate Sulfurtransferase Homo sapiens 377/437 86% NM_003312.1 
 EQUK86 FK506-Binding Protein Bos taurus 563/611 92% M95123 
 EQUK98 Epidermal Protein E-FABP Bos taurus 458/510 89% AF059507 
 EQUK114 ADP-Ribosylation Factor 4 Homo sapiens 309/350 89% AF104238 
 EQUK143 Clathrin Heavy Polypeptide 2  CLTCL2 Homo sapiens 237/269 86% NM_004859.1 
 EQUK173 Karyopherin alpha 4 Homo sapiens 274/305 89% NM_002268.1 
 EQUK239 Endoplasmic Reticulum Translocon Homo sapiens 288/340 84% NM_007214.1 
 EQUK244 Vacuolar Sorting protein 35 Homo sapiens 239/274 87% AF191298.1 
 EQUK253 Vacuolar H-ATPase subunit D Homo sapiens 352/379 92% AF100741.1 
 EQUK269 NaPi-2 beta  Rattus norvegicus 243/270 90% AB013454 
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 EQUK273 Sialomucin CD164 Homo sapiens 165/184 89% NM-006016.1 
 EQUK292 Valosin Containing Protein Homo sapiens 118/131 90% AC004472 
 EQUK349 Emopamil-binding protein  Homo sapiens 177/209 84% NM_006579.1 
 EQUK352 Epidermal Fatty Acid-binding protein  Bos taurus 274/301 91% AF059507 
 EQUK395 Sterol carrier protein-2  Homo sapiens 224/246 91% M55421 
 EQUK420 Karyopherin alpha 4  Homo sapiens 259/295 89% NM_002868.1 
       
Unclassified EQUK54 CAG-isl 7 Homo sapiens 402/440 91% U16738 
 EQUK58 Hypothetical Protein Homo sapiens 260/296 87% AJ012409 
 EQUK102 EB1 Homo sapiens 327/356 91% U24166 
 EQUK103 Tumor Protein 1  Translationally-
controlled 1 
Homo sapiens 512/560 91% NM_003295.1 
 EQUK108 Cisplatin Resistance Associated Alpha  Homo sapiens 99/109 90% U78556 
 EQUK112 Platlet Activating Factor 
Acetylhydrolase 
Homo sapiens 193/204 94% U72342 
 EQUK132 KIAA0869 Homo sapiens 313/337 92% AB020676.1 
 EQUK153 S164 gene Homo sapiens 142/168 84% AF109907 
 EQUK212 Calpactin 1 Bos taurus 504/557 90% M14056 
 EQUK220 KIAA1012 Protein Homo sapiens 274/305 89% AB023229.1 
 EQUK228 KIAA0761 protein Homo sapiens 124/142 87% AB018304.1 
 EQUK271 23KD Highly Basic Protein Homo sapiens 234/256 91% X56932 
 EQUK291 DKFZp66J2146 Homo sapiens 210/236 88% AL050081.1 
 EQUK319 KIAA0313 Homo sapiens 472/503 93% AB002311 
 EQUK320 Heat Shock Protein Alpha-Delta-N Homo sapiens 404/460 87% AF028832 
 EQUK329 Novel gene Homo sapiens 457/503 90% M73791 
 EQUK330 KIAA1102 protein Homo sapiens 188/207 90% AB029025.1 
 EQUK331 S100 calcium-binding protein A7  Homo sapiens 215/255 84% NM_002963.1 
 EQUK343 NESCA Homo sapiens 263/305 86% AB026894.2 
 EQUK467 Heat Shock protein 40 Mus musculus 346/430 80% AB028272.1 
  1:The classification of the ESTs based on their putative identification. 2: The clonal designation 
assigned to each EST as part of inventory tracking. 3:The putatively identified protein or gene 
which had the highest homology with the corresponding EST. 4: Species, refers to the organism 
with highest score returned from NCBI’s BLAST similarity search for the relevant EST. 5: ID 
The first number designates the number of base pairs of the EST query which were identical to 
the putative nucleotide sequence, in this case the second number. 6: The percent of nucleotide 
identity shared by the EST and the corresponding homologous sequence. 7: Accession number of 
the matched sequence. 
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Chapter Seven 
Summary and Conclusion 
 
This research project has provided evidence that Epitheliogenesis Imperfecta (EI) in 
American Saddlbred horses is a simple recessive disease confirming the reports of Johnson et al., 
1988 and Kuhn et al., 1989. A strong correlation was demonstrated between the pathological 
signs of EI and Herlitz Junctional Epidermolysis Bullosa (HJEB) in humans. Examination of the 
ultrastructure of skin samples from EI foals showed a clean separation in the basement 
membrane between the lamina lucida and the lamina densa indicating that a defect in laminin 5 
was responsible for EI. Analysis of Linkage disequilibrium (LD) provided evidence that in 
American Saddlebred horses, LAM α3 on ECA 8 may contain the causative mutation. A cDNA 
library was constructed and characterized as a tool for sequencing skin transcripts, specifically 
the laminin 5 subunits. 
The pathological signs of EI in two American Saddlebred foals were characterized by 
necropsy examination. Lesions generally occur on the body and limbs, in the mouth and at the 
interface between the anus, genitals and skin (Figs.11, 12, 15&16). Dental abnormalities such as 
irregularities in tooth appearance were observed (Fig 13&14). Necropsy results revealed normal 
internal organs and failed to reveal any signs of pyloric atresia or intestinal blockages (Figs. 17-
25). A defect in an attachment protein common to the skin and oral mucosa and with a role in 
tooth development would account for the pathological signs observed in this disease. 
The structural homology of skin across mammalian species allowed comparisons to be 
made between equine EI and human EB subtypes. EI was shown to bear a strong resemblance to 
human HJEB (Fig. 27&28). Epitheliogenesis Imperfecta and HJEB both share similar a similar 
pathology. All known cases of HJEB are due to a premature stop codon in one of the laminin 5 
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subunits, which results in a lack of expression of that particular protein chain (Aberdam et al., 
1994; Baudoin et al., 1994; Vidal et al., 1995). Careful examination of the Saddlebred necropsy 
results found that they were consistent with a defect in the laminin 5 attachment protein.  
 Research by Butz et al. (1957) indicated that EI had a simple recessive mode of 
inheritance. Construction of a partial pedigree in American Saddlebred horses showed the 
probable lines of inheritance. Analysis of the offspring, particularly those from sire 70 met the 
expectations of a recessive inheritance model. A recessive mode of inheritance for EI is 
consistent with a defect in one of the laminin 5 subunits. The three subunits form a heterotrimer 
protein. Individuals, which carried a single laminin 5 subunit disease allele, would be able to 
compensate for a defective or nonexistent subunit through expression of the copy of the non-
disease subunit.  
Dental abnormalities have been previously described in Saddlebred EI affected foals and 
were observed here. These are deduced to be due to abnormalities in the process of 
odontogenesis (Dubielzig et al., 1986). In humans it has been reported that junctional epithelium 
cells preferentially bind to laminin 5 coated areas of the teeth (Mullen et al., 1999). This suggests 
laminin 5 plays a necessary role in normal tooth development and that absence of laminin 5 
could disrupt normal tooth development. 
The hemidesmosome attachment structure, mediated by α6β4 integrin/ laminin 5 
interaction, is required for stable adhesion to the basement membrane. Focal adhesion 
complexes, mediated by α3β1 integrin/laminin5, are the primary attachment structures used by 
cells for motility, such as embryonic development and wound repair (Smilenov et al., 1999). 
Epithelial cells, cultured without laminin 5, show drastically reduced mobility compared to 
epithelial cells cultured with laminin 5 (Goldfinger et al., 1999). This suggests that an in vivo 
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absence or defect in laminin 5 would not only affect hemidesmosome formation but also dental 
development and wound healing. 
 Examination of the TEM results revealed a separation between the lamina lucida and 
lamina densa layers of the basement membrane in Saddlebreds (Fig 32,33&36). The 
organization and structure of the skin is nearly identical across mammals. In humans, a 
significant body of research has established the precise location and likely interactions of the 
proteins in the basement membrane. Application of the human skin model (Fig. 4) to the TEM 
results supported the laminin 5 protein as the most likely candidate to contain a defect 
responsible for EI. The TEM results ruled out a collagen VII defect since, based on observations 
from human dystrophic EB, one would expect a separation below the lamina densa (Christiano et 
al., 1996). Signs of pyloric atresia in EI affected foals would be expected if the causative defect 
was in either the α6 or β4 integrin, based on observations from human Hemidesmosomal EB 
(Gache et al., 1998; Niessen et al., 1996; Vidal et al., 1995). 
 Defects in any of the three subunits of the laminin 5 protein could result in the EI 
pathology. Using information from the equine genome map, 11 microsatellite markers were 
selected for Linkage Disequilibrium analysis of EI. The microsatellites examined were those 
likely to be in physical proximity with the putative location of the laminin 5 subunits. In 
Saddlebred EI affected foals phenotypic frequencies at both AHT3 and ASB14 were not found to 
be in Hardy-Weinberg equilibrium. Furthermore, all of the Saddlebred horses genotyped were 
homozygous for the AHT3-141 allele, indicating haplotype association of EI with AHT3-141. 
Seven out of nine Saddlebred horses were homozygous for ASB14-113 and in phase with AHT3-
141. A recombination event could account for the two heterozygotes at ASB14. Since AHT3 and 
LAM α3 both map to chromosome 8 this supports that LAM α3 contains the causative mutation 
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for EI. Analysis of the results for the Belgian Draft horses did not provide evidence supporting 
any of the laminin 5 subunits as the EI disease locus. This suggests that the EI mutation in the 
Belgian Draft horses is either the same mutation but with multiple haplotypes or that it is a 
different mutation in one of the other subunits. Sequencing the laminin 5 subunits in horses 
would be useful for clarifying the situation. Additional EI affected individuals and further 
genotype testing of AHT3 and ASB14 should strengthen the evidence for linkage disequilibrium 
of these microsatellites with the EI locus.  
 An equine skin cDNA library was constructed in order to provide a resource for the study 
of representative genes transcribed in the skin. Three hundred and thirteen ESTs were sequenced 
of which 207 were putatively identified with homologous genes via database search. Twenty two 
ESTs were identified as skin specific transcripts. 
 Probes were designed from the human homologues of the LAM α3, LAM β3 and the LAM 
γ2 subuits in order to screen the cDNA library. Only the primers for the LAM γ2 probe 
successfully amplified the targeted sequence from horse genomic DNA. Due to non-specific 
binding interactions this probe was not useful for isolating a clone containing the equine LAM γ2 
transcript. Future probing and sequencing efforts will target LAM α3, since the LD analysis 
supports LAM α3 as the disease locus. 
 This study defined the pathology of EI, identified the location of ultrastructural defects in 
the skin and indicated that laminin 5 was defective in EI affected foals. The LD analysis 
suggested that the gene coding for the LAM α3 subunit of laminin 5 contained the defect 
responsible for EI. While it was not possible to conclusively identify a mutation in any of the 
subunits of laminin 5, a horse skin cDNA library was constructed to serve as a resource for 
further endeavors. 
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APPENDIX i 
 
 
Specimen preparation for Transmission Electron Microscopy 
 
 
Samples were cut to 1 mm cubes and placed in a solution of 3% glutaraldehyde (in 
sorensons buffer) for 3 hours. Samples were stored in sorensons buffer until use. Samples were 
then selected for osmication or normal processing. Osmicated samples were placed in a solution 
of 1% osmium tetraoxide in sorensons buffer for 1 hour. This was followed by two brief washes 
in sorensons buffer.  
 All samples were dehydrated as follows: 10 min immersion in 40% ethanol, then a 10 
min immersion in 50% ethanol, then a 15 min immersion in 70% ethanol and 2% uridyl acetate. 
A brief wash in 70% ethanol, then 10 min immersion in 70% ethanol, then a 10 min immersion 
in 80% ethanol, then a 10 min immersion in 95% ethanol followed this. Lastly the samples were 
immersed twice for 30 min each in 100% ethanol. This was followed by 2 immersions in 100% 
propylene oxide (PO) for 1 hour each. Then the samples were immersed in a 50/50 PO/resin 
mixture for 24 hours under vacuum. The samples were placed in 100% resin for 1 hour in shell 
vials. This was followed by sample placement in flat molds in 100% resin for 1 hour, then 
repeated. 
The samples were lastly placed in flat molds and beam capsules and placed in an oven at 
60°C for 3 days. 
 
The resin formula used was: 
  Epon 812  62mL 
  Araldite 506  81mL 
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  DDSA   100mL 
  Dibutyl pthalate 5mL 
  DMP-30  2%v/v 
 
Sorensons buffer is: 
  Potassium phosphate    8g 
Sodium phosphate heptahydrate 37.4g 
  dH2O     1L 
 
Bring the pH to7.2 with NaOH. 
 
Section Preparation 
 
 Sections were cut on an ultramicrotome. The resin blocks were thick sectioned 
with a glass knife, then thin sectioned with a diamond knife to 100nM in thickness. The 
sections were placed on 200 mesh copper grids and stained. The sections were stained in 
uranyl acetate for 15 min followed by three washes in dH2O. The sections were then 
stained in lead citrate for 15 min followed by three washes in dH2O.  
 
Lead Citrate stain was made up as follows: 
  Lead Citrate   0.12g 
  Sodium hydroxide         3 pellets 
  Boiled dH2O    30mL 
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Mixed by inversion then centrifuge  
Total volume was the brought up to 50mL with dH2O 
Before use the stain was filtered via syringe and 2 micron Millipore filtration 
 
Uranyl Acetate (3% ) stain was made up as follows: 
  Uranyl Acetate  1.5g 
  dH2O    50mL 
Mix by inversion, then centrifuge. 
Before use the stain was filtered via syringe and 2 micron Millipore filtration 
 
Sections were then examined via transmission electron microscopy on a Hitachi 7000 
Electron Microscope. Similar protocols were described by Hayat et al. (1970). 
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Marker Testing Protocol for Analysis of Linkage Disequilibrium 
Dye labeled Primers based on these markers were produced by Perkin Elmer and 
used for Genescan analysis. The primer sets were placed into multiplexes (based on 
expected product size and fluorescent tag) of several primer sets each. All primers were 
diluted to a working dilution of 10pM . The multiplex cocktails were made up as follows: 
multiplex 1 
LEX25 1uL For/1uL Rev 
LEX04 2uL For/2uL Rev 
ASB14 1uL For/1uL Rev 
Bring up to 40uL with Sigma PCR grade water 
Single Reaction 2 
HTG15 6uL For/6uL Rev 
Bring up to 40uL with Sigma PCR grade water 
multiplex 3 
VHL20 2uL For/2uL Rev 
AHT3 6uL For/6uL Rev 
Bring up to 40uL with Sigma PCR grade water 
multiplex 4 
ASB38 2uL For/2uL Rev 
ASB17 2uL For/2uL Rev 
HMS18 2uL For/2uL Rev 
Bring up to 40uL with Sigma PCR grade water 
 92 
multiplex 5 
AHT24 2uL for/2uL Rev 
HTG20 6uL For/6uL Rev 
Bring up to 40uL with Sigma PCR grade water 
 
The reaction mix contained 6uL of Sigma PCR grade water, 1.25uL of Perkin 
Elmer Goldamp PCR buffer, .5uL of dNTP’s, 8uL of primer cocktail, .12uL of Perkin 
Elmer Taq Gold Polymerase and 1.25uL of magnesium (25 mm). To this reaction mix 
was added either 1uL of DNA at 25 ng per ul or 2uL of prepared sera.  
The reaction mix was amplified on an DNA thermocyler (MJ Research) as follows, 95°c 
for 15 minutes followed by 36 cycles of 95°C for 1 minute, 55°C for 30 seconds, 72 °C 
for 1 minute. This was followed by 30 minutes at 72°C then 4 °C until removal. 
 The PCR product was prepared for analysis by removing .6uL of the PCR 
reaction and adding it to 1.6uL of loading buffer mix. The loading buffer contained 90uL 
deionized formamide, 25uL Perkin Elmer loading dye and 10uL Rox 350 size standard. 
The loading buffer and sample were heat denatured at 95 °C for 3 minutes followed by 
quick cooling on ice. 2uL of the product/loading buffer mix was electrophoresed on a 12 
inch 6%(19:1) polyacrylamide gel on an ABI 377. The results were analyzed using 
Genotyper software (ABI). Microsatellites size information was recorded for each 
Belgian and Saddlebred EI sample and for the control Saddlebred and Belgian horses. 
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cDNA Library Construction and Characterization Protocol 
 
Total RNA Extraction 
 
1. Skin was shaved and dissected from a freshly euthanized horse then flash frozen in an 
RNAse-free 50mL conical tube containing liquid nitrogen. 
2. The skin was placed in a container in a liquid nitrogen bath then the epidermal skin 
surface was crosscut with a scalpel. Similar procedures were used by Hipfel et al. 
(1998). The skin was then processed using the Rneasy Maxi kit from Qiagen. 15 mL 
of buffer RLT with beta mercaptoethanol (a potent RNAse inhibitor) was added to 
each tissue section and the tissue was homogenized with a tissue grinder in a 50 mL 
sterile RNAse free conical tube.  
3. The tube was centrifuged at 3000-5000xG for 10 min. The upper layer was 
transferred, without disturbing the fatty layer or pellet, into a new Rnase free 50 mL 
conical tube. An equal volume of 70% ethanol made with DEPC treated dd H2O was 
added and mixed by shaking.  
4. 15mL of the solution from step 3 was added to a Qiagen RNA column and 
centrifuged at 3000-5000xG for 5 minutes. The flow through was discarded then the 
remaining solution was added to the column. Centrifuge again and discard the flow 
through. 
5. 15mL of buffer RW1 was pipetted onto the column and the tube was centrifuged at 
3000-5000xG for 5 min. Discard flow through. 
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6. 10mL of the wash buffer RPE (make sure the 100% Ethanol has been added) was 
pipetted onto the column and centrifuged at 3000-5000xG for 2 minutes. 
7. 10 mL of wash buffer RPE was pipetted onto the column and centrifuged at 3000-
5000xG for 10 min. 
8. The RNA column was transferred to a new Rnase-free sterile 50mL conical tube. .2 
mL of Rnase free dd H2O was added to the center of the column and centrifuged at 
3000-5000xG for 3 min. This was repeated with another 1.2mL d H2O. The 
flowthrough from both passes as it contains your RNA.  
9. The RNA was diluted 1:10 with DEPC- H2O and the OD260 and OD280 were read 
on a Spectrophotometer. 
 
mRNA Isolation 
10. Prepared Poly A Quick push columns from Stratagene were used to separate mRNA 
from total RNA. The RNA was diluted to Stratagene's specifications with DEPC 
treated d H2O. Ex.-174uL RNA add 6uL DEPC- H2O and 20uL (SM) Sample 
buffer.(Add 3M NaOAc to the unused RNA, precipitate with 100% EtOh and store at 
–70C.) Heat at 65°C for 5 min then place on ice.  
11. The RNA elution buffer was pre-heated at 65°C. 
12. Both end caps of the RNA push column were removed. The plunger of a 10cc Luer-
Lock syringe was extended and the syringe was attached to the push column. Slowly 
(approximately one drop every two seconds) the storage buffer was pushed out of the 
column and collected in a waste beaker. It was important to push slowly to insure 
uniform column packing. 
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13. The syringe was removed and 600uL of high salt RNA buffer was added to the 
column. The buffer was pushed all the way through at the rate of one drop every two 
seconds. This was repeated two more times with 600uL of high salt buffer. 
14. The heated RNA sample was applied to the column and pushed through at a rate of 
approximately one drop every two seconds. A sterile microfuge tube was used to 
catch the effluent. The RNA sample was reapplied 3 more times. The last passage 
was saved and labeled A-RNA. 67uL of the A-RNA was added to 168uL ice-cold 
100% EtOh and store at –70°C.  
15. 200uL of high salt RNA buffer was applied to the column at one drop per second into 
a waste beaker and repeated. 
16. The column was washed three times using 200uL aliquots of low salt RNA buffer 
into a waste beaker. 
17. The mRNA was eluted using one 400uL aliquot of RNA elution buffer that had been 
preheated to 65°C in a temperature block. This was pushed through at one drop per 
second. The elution buffer was re-applied one more time. This effluent was saved in a 
microtube labeled A+ RNA. 100uL of the effluent was placed in a separate 
microtube. 
18.  The sample of poly A+RNA was precipitated. 30uL of 3M NaOAc and 750uL cold 
100% ethanol was added to the 300uL effluent microtube. 10uL 3M NaOAc and 
250uL cold 100% ethanol was added to the 100uL effluent microtube. Store at –70°C. 
19.  The 300uL microtube was spun at top speed in a microfuge at 4°C for 60 min to 
pellet the precipitated RNA. The tubes were orientated with the cap hinge outward so 
as to pellet the RNA below the hinge.  
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20. The ethanol was removed with a flame drawn pasteur pipette, taking care not to 
disrupt the pellet.  
21. The pellet was washed by adding 500uL of 70% cold EtOH and rocking the tube 
gently back and forth for 15 seconds. This step was designed to wash the pellet. The 
tube was spun in a microfuge at top speed at 4°C for 5 min. 
22. The ethanol was removed with a flame drawn pipette, the tube was then spun for 30 
seconds in a microfuge and any residual ethanol was removed with the flame drawn 
pipette. The open tube was placed on ice for 5 min to air dry. 
 
cDNA Synthesis 
23. The first strand cDNA reaction mix was prepared by mixing the following 
components in a new microfuge tube. 
5.0uL 10X first-strand buffer (Stratagene buffer #1) 
3.0uL methylated dNTP mix 
2.0uL linker-primer (1.4 ug/ul) 
 
Note: The sequence of the linker-primer is 5’(GA)10ACTAGTCTCGAG(T)133’ 
24. The tube was mixed by tapping, then spun for 5 seconds in the microfuge and placed 
on ice. 
25. 37.5uL DEPC-treated H2O was added to the microfuge tube containing 1.0uL RNAse 
inhibitor (40U/uL). 
26. After removing all of the ethanol from the poly A+RNA tube all of the diluted 
RNAse inhibitor was added then resuspend by pipetting up and down for 1 min. 
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27. The 10uL first-strand reaction mix was added to the resuspended Poly A+ RNA and 
mixed. The tube was spun for 5 seconds in a microfuge. 
28. The tube was placed in a rack for 10 minutes at room temperature to allow the olgio 
d(T) primer to anneal to the poly A+ tails of the mRNAs. 
29. After the 10 minute annealing period, 1.5uL of reverse transcriptase at (50U/uL) was 
added and mixed briefly with a pipette tip. Incubated for 1 hour at 37°C. Synthesis of 
first-strand cDNA occurred during this time. 
30. The tube was removed from the 37°C water bath, spun briefly in a microfuge and 
placed on ice.  
31. The following was added on ice: 
20.0uL 10X second-strand buffer (Stratagene buffer 2 ) 
6.0uL dNTPs 
116.0uL dH20 
32. This was mixed by pipetting up and down and spun for 5 seconds in the microfuge 
and then the following was added: 
2.0uL Rnase H (1.5 U/ul) 
11.0uL DNA polymerase 1(9U/uL) 
33. This was mixed briefly with pipette tip, spun for 5 seconds in the microfuge and 
placed in a water bath at 16°C for 2.5 hours. Removal of the original RNA template 
and synthesis of the second strand of cDNA occurred during this time. After 2.5 hours 
remove and place on ice. 
34.  To generate perfectly blunt ends on the ds cDNA Pfu polymerase was used to fill in 
or degrade ragged ends. The following ice cold components were added: 
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23.0uL Blunting dNTP Mix 
2.0uL Pfu polymerase (2 U/ul) 
35. The reaction components were quickly mixed with a pipette tip then spun for 5 
seconds in a microfuge and placed the tube in a 72°C block for exactly 30 Min. This 
was immediately placed on ice. 
 
cDNA Purification 
36. The tube was spun briefly in a microfuge and the entire 225uL ds cDNA reaction was 
transferred to a (Eppendorf/ 5prime-3 prime) pre-spun phase lock gel microtube. 
37. 200uL buffered Phenol was added to the tube and mixed by vortexing for 30 seconds. 
38. 200uL chiasm (24:1 chloroform:isoamyl alcohol) was added and mixed by vortexing 
for 30 seconds. 
39. The tube was spun in a microfuge at maximum speed for 10 min. 
40. The upper aqueous phase was transferred to a new microtube labeled ds cDNA. 
41. 30uL 3M Sodium Acetate (pH 5.2) was added  and mixed with the contents briefly, 
then 400uL ice-cold 100% ethanol was added. The tube was closed and mixed by 
inverting several times and store at -20°C for 30-60 min to allow the cDNA to 
precipitate. 
42. The tube was placed in a microfuge with lids pointing outwards and centrifuged for 
60 minutes at top speed at 4C. 
43. The ethanol was removed using a flame drawn pipette being carefuL not to disrupt 
the pellet.  
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44. The pellet was washed by adding 500uL 70% ethanol(added carefully to the side of 
the tube opposite the pellet).  
45. The tube was placed hinge outwards, back into the microfuge and spun at top speed 
for 5 min. 
46. The ethanol was removed with a flame drawn pipette. 
47. The tube was spun in a microfuge for 30 sec, then any residual ethanol was removed 
with a flame drawn pipette and the open tube was placed on ice for 5-10 min to let the 
pellet dry. 
 
Eco R1 Adapters 
48. 9.0uL of the EcoR1 adapters was added to the tube containing the dry cDNA pellet. 
Without pipetting, the tube was allowed to stand on ice for 15 min. to ‘soften’ the 
pellet. 
Note the EcoR1 adapters are 5’ AATTCGGCACGAG 3’ 
     3’ GCCGTGCTC 5’ 
49. The pellet was resuspended by pipetting up and down using a clean pipette.. 
50. The tube with the cDNA and EcoR1 adapters was placed on ice and the following 
reaction components were added. 
1.0uL 10X ligase buffer 
1.0 ul rATP (10mM) 
1.0uL T4 DNA ligase (4 U/ul) 
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51. The reaction components were mixed with a pipette tip,  spun for a few seconds in a 
microfuge then incubated at 8°C overnight. The EcoR1 adapters were ligated to the 
blunt ends of the ds cDNA during this time. 
 
  
52. The tube with the cDNA (now with EcoR1 ends) was placed in a waterbath at 70°C 
for 30 min. 
53. The tubes were spun for 5 seconds in a microfuge and placed on ice. 
     
Kinase the Ends 
54. Prior to the ligation of the ds cDNA to the dephosphorylated lambda vector arms the 
ends of the cDNA were kinased. The following reaction components were added on 
ice. 
1.0 ul 10X Ligase buffer  
2.0 ul rATP (10mM) 
6.0uL dd H2O 
1.0 ul T4 polynucleotide kinase (10 U/ul) 
55. The reaction components were mixed with a pipette tip, then spun for 5 seconds in a 
microfuge and placed in a 37°C waterbath for 30 minutes. A Phosphate group was 
added to the 5’ends of the ds cDNA during this time. 
56. After the 30 minute incubation is complete, placing the tube in a heat block at 70°C 
for 30 minutes to heat inactivate the kinase stopped the reaction.  
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57. After heat-inactivating the kinase the tube was spun for 5 seconds in a microfuge and 
placed in a rack at room temperature for 5 minutes to allow the contents temperature 
to reach equilibration. 
 
Xho 1 the Ends 
58. 28uL Xho1 buffer supplement was added and mixed by pipetting up and down. Then 
3.0uL Xho1 was added and mixed briefly with a pipette tip and the tube was spun in a 
microfuge and placed in a waterbath at 37°C for 1.5 hours. 
59.  The tube was spun for 5 seconds in a microfuge and cooled at room temperature for 
5 min. 
 
Size select the cDNA 
60. A Clonetech Chromaspin-400 column was used to size select the insert cDNA. The 
chromaspin column was prepared by vortexing the column, with the caps on both 
ends, several times to distribute the column material in the buffer. 
61. The cap was removed from the top end and the bottom tab was removed. The narrow 
end of the column was placed in the special screw-top microfuge tube provided by 
Clonetech. 
62. The column and microfuge tube were placed into a 15 mL conical centrifuge tube and 
spun at 700 G for 3 min. 
63. The column was removed from the microfuge tube and discarded. The column was 
placed into a second new screw-top microfuge tube. 
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64. 5uL of .1% bromphenol blue dye was added to the tube containing the ds cDNA and 
mixed by tapping the tube. This was spun for 5 seconds in a microfuge. 
65. All of the cDNA plus bromphenol blue dye was pipetted into the middle of the 
prepared Chromaspin column.  
66.  The column assembly was spun at 700X G for 5 min. About 65uL of cDNA was 
recovered.  
 
cDNA Purification II 
67.  dd H2O was added to bring the total volume up to 100uL. 
68. 100uL of cDNA was added to a into an (Eppendorf/ 5prime-3prime) phase-lock gel 
tube. 
69.  50uL buffered phenol was added to the phase lock and vortexed. 
70. 50uL chiasm (25:1 chloroform:isoamyl alcohol) was added to the phase lock tube and 
vortexed for 30 sec. 
71. This tube was spun at top speed for 2 min in a microfuge. 
72. The upper aqueous phase was transferred to a new pre-spun phase lock tube. 
73. 100uL chiasm was added to the phase lock tube and mixed by vortexing for 30 sec. 
74. This tube was spun for 2 min in a microfuge. 
75. The upper aqueous phase was removed and placed on a dialysis membrane. 
76. 30 mL Sigma dd H2O was poured on a clean petri dish. A 45nm diameter Millipore 
(.025um pore sz filter) membrane filter was floated, shiny side up, on the water 
surface. The filter was allowed to wet for about 5 min without submerging the filter. 
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77. All of the aqueous phase (about100uL) was carefully pipetted onto the center of the 
dialysis filter. 
78. The dish was covered and left for 4 to 5 hr. 
79.  As much of the cDNA as possible was carefully retrieved with a pipette and 
transferred to a new microtube. 
80. The volume of the cDNA was reduced by vacuum drying until it was just less than 
5uL. 
81. The volume was brought up to 5uL with Sigma dd H2O. 2.5uL of the cDNA was 
removed for ligation and the rest was stored at-20. 
 
Ligation 
82. The following components were added to the 2.5uL of cDNA: 
0.5uL 10X ligase buffer 
0.5uL rATP (10mM) 
1.0 ul Uni-ZAP XR lambda vector (already cut with EcoR1 and Xho1 and 
dephosphorylated). (1ug/uL) 
0.5uL T4 ligase 
5.0 Total Volume 
83. The reaction components were mixed with a pipette tip and spun for 5 seconds in a 
microfuge then incubated at 12°C overnight. 
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Bacteria CuLture Prep. 
84. An overnight cuLture of plating bacteria was started to prepare for plating the library. 
For Lambda Uni-ZAP the recommended host bacterium was the XL-1 Blue MRF 
Strain. A single colony of these bacteria was picked from a streak plate and used to 
inocuLate 10 mL of NZYDT medium and grown in a small flask or 50 mL centrifuge 
tube at 30°C overnight with vigorous rotation to ensure aeration of the cuLture. The 
next morning the bacteria were pelleted by centrifuging them at 2000 RPM in a 
tabletop centrifuge at 4°C for ten minutes. The supernatant was then poured off and 
the bacteria gently resuspended in 5mL of 10mM MgSO4. The OD was then 
measured, using plastic disposable quvettes, at 600nm and the cuLture further diluted 
with 10mM MgSO4 until the OD600=.6-.62. These bacteria were then kept on ice 
until needed for the plating procedure that followed the packaging procedure. 
 
Packaging 
85. The tubes of packaging extract were kept frozen immediately before use. Each tube 
was quickly warmed between my fingers until it just began to thaw.  
86. Immediately all 5uL of the cDNA-Lambda ZAP ligation reaction was added to the 
extract tube and placed in a rack at RT. This was stirred gently with a pipette tip, 
taking care not to introduce air bubbles. 
87. The extract tube was spun for 5 sec in a microfuge and incubated at room temperature 
for 2 hours.  
88. Following the two hour incubation, 500uL SM buffer (phage storage buffer) and 
20uL chloroform was added to the extract tube. Then the contents of the extract tube 
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were transferred to another microtube and labeled cDNA Lib. This was spun briefly 
in a microfuge to sediment the debris and stored at 4°C. 
 
Titer the Library 
89. An undiluted sample of packaged lambda phage was prepared. 1uL of packaged 
bacteriophage from the cDNA library was added to a microfuge tube containing 
200uL of plating cells and mixed by flicking 
90. A diluted sample of packaged lambda phage was prepared, 1uL of packaged phage 
from the cDNA library tube was added to 49uL of SM buffer. The tube was tapped 
then spun for 5 seconds in a microfuge to mix it. 1uL was then added to a microfuge 
tube containing 200uL of plating cells. The remainder of the library was stored at 
4°C. 
91. Both tubes were incubated at 37°C for 15 min. The lambda phage adhered to the host 
bacterial cells during this time. Following incubation the tubes were kept in a rack at 
room temperature until it was time to plate them out. 
92. 15uL of 0.5 M IPTG was added to tubes containing 3mL of molten NZY top agarose 
in a water bath at 50°C and vortexed.  
Recipe for NZY top agarose 
0.6 grams agarose per 100 mL of NZY medium before autoclaving 
 
93. 2 day-old pre-warmed NZY plates were labeled cDNA library and diluted and 
undiluted. 
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94. To the tube of NZY top agarose 50uL of 250 mg/mL X-gal was added then vortexed 
briefly and placed into a 50°C water bath. The tube labeled Undil was flicked then all 
200uL was added to the tube of NZY top agarose followed by brief vortexing then it 
was poured immediately onto the NZY plate labeled Undil. This procedure was 
repeated for the 1:50 dilution. 
95. The plates were left upright on the bench for 5-10 min to harden. They were then 
inverted and incubated at 37°C overnight. During this time the bacteria grew and 
those infected by phage lysed to form plaques. Bacteriophage with intact β−gal genes 
(without an insert) formed blue plaques, while those with disrupted β−gal genes will 
form clear plaques. 
96. The diluted plate was selected and all of the plaques were counted The number of 
blue and clear plaques also were counted. 
 
Average Insert Size and EST collecting 
97. The average insert size of the cDNA library was then calculated. The same procedure 
was used for collecting and purifying clones before EST sequencing. An average 
insert size of 1.0-1.5 kb is generally indicative of full-length cDNAs in mammals. 
The average insert size was calculated by picking 20 clear plaques at random and 
using PCR primers complementary to sites flanking the cloning site in the UNI-ZAP 
vector to amplify the insert from each vector. 
98. 50uL SM buffer was added to each microfuge tube, 1 tube for each plaque picked. 
 107 
99. A 1000uL pipette tip was used to pick an isolated clear plaque from one of the plates 
and transfer it into a microtube. This was repeated as necessary using a new pipette 
tip each time. 
100. Each tube was vortexed for 1 minute to release the phage particles into the SM 
buffer. 
101. The tubes were incubated at 37°C for 1 hour. The higher temperature helps to release 
the phage particles from the agar plug. 
102. The tubes were removed and vortexed again for 1 minute each. 
103. All the tubes were spun for 2 minutes in the microfuge to sediment unwanted 
agarose particles. 
104. A PCR Master Mix was set up so that a single reaction mix would be: 
31.5uL d H2O (Sigma PCR grade water) 
8.0 ul dNTP mix (20uM) 
5.0  ul 10X PCR reaction buffer (Perkin Elmer GoldAmp) 
3.0  ul MgCl2 (25mM) 
1.0 ul T3 primer (forward) 10pM 
1.0 ul T7 primer (reverse) 10pM 
0.5  ul  Taq Gold polymerase (Perkin Elmer) 
105. This was mixed by pipetting up and down. 46uL of the PCR Master Mix was added 
to each of the thin-wall PCR tubes and 4uL of the stock phage solution was added 
from each microfuge tube to the PCR tube. 
106. PCR was performed on a PTC 200 thermocycler (MJ Research) as follows: 94°C for 
12 min then 55°C for 5 min then 72°C for 90sec then 35 cycles of 94°C for 45 sec 
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then 55°C for 45 sec then 72°C for 90 sec. A final extension step of 72°C for 10 min. 
4°C forever 
107. The PCR products were electrophoresed on a 1% agarose gel with ethidium bromide 
and the bands were visualized with U.V. light. Product lengths were calculated based 
on comparison with Biomarkers size standards (Bio Ventures Inc.). 
 
ESTs 
108. After amplification, 7% DMSO (final volume) was added to the picked clones and 
they were stored at –80°C. 
109. Relevant bands were cut from the agarose gel and purified with Qiagen’s gel 
purification kit. 
110. A labeling RXN was performed Perkin Elmer’s Big Dye terminators according to 
the manufacturers protocol. 
111. The labeled products were cleaned of primers and unicorporated dye terminators 
using Qiagen’s Dye X columns. 
112. The cleaned sample was vacuum dried and resuspended in with a mixture of 5:1 
deionized formamide: Perkin Elmer loading dye. The sample was then vortexed and 
vortexed for 5 sec at high speed on a microfuge. The samples were then heat 
denatured for 2 min at 95°C and quick cooled on ice. 
113. The samples were sequenced on an ABI 377 using Sigma Autopage 4.5% 
acrylamide and 36 inch plates on a 7 hour run. 
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Library Screening 
Label the Probe 
 Similar approaches were used when using DIG and P32 labeling methods. 
Boerhinger Mannheim’s DIG labeling protocol uses a colormetric developing step 
directly applied to the filter in which dark spots reveal positive clones. The P32 protocol 
allows direct application of  the filter to x-ray film following the stringency washes 
avoiding the conjugate antibody application steps of the DIG and Fluoroscein methods. 
In all labeling methods a control was run through the same procedures as the plaque lifts 
and it was always positive. 
 
114. Consensus primers were designed based on the sequence of human LAMγ2 exon 9 
and used to amplify a single 182 bp band from horse genomic DNA. 
115. This band was  purified via Qiagen kit purification and sequenced. It was verified to 
have 90% sequence identity to the human LAMγ2 exon 9 sequence. 
116. The horse LAMγ2 probes sequence was 
5’CCCCCTCCCGTTTCTGGAGCCCAGCNCCCTGGGTTGAACAATGTGTATGCCCTGTT
GGCTACAAGGGGCAGTTCTGCCAGGATTGTGCTTCCGGCTACAAAAGAGATTCAGCC
AGACTGGGACCTTTTGGCACCTGTATTCCATGTAACTGCCAAGGGGGAGGGG3’ 
117. The probe was labeled using Amersham’s ECL 3’ olgiolabeling and detection 
systems kit. 
118. 4 ng of the probe DNA was diluted in 31uL Sigma water. 
119. This was added to the following Reaction mix: 
5uL 10x PCR buffer 
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5uL FL-dUTP (Fluorogreen) 
3uL dNTP (1:1:1) of 10mM dATP, dGTP, dCTP) 
3uL 25 mm MgCl2 
1uL  Forward primer (10 pmol/ul) 
1uL  Reverse primer (10pmol/uL) 
.5uL 10 mm TTP 
.5uL Taq Gold Polymerase (Perkin Elmer) 
50uL Total Volume 
120. This was mixed and  then run with the following PCR program: 94°C for 12 minutes 
then 30 cycles of 94°C for 60 sec. Then 50°C for 60 sec then 72°C for 90 sec. Then a 
final elongation step at 72°C for 7 min and hold at 4°C. PCR was performed on a 
PTC 200 thermocycler (MJ Research). 
121. The tube was then stored at –70°C.  
 
Plaque Lifts 
122. The plates were refrigerated for 1 hour before lifting. 
123. A ball point pen was used to label the filters (Millipore Immobilon Ny+) with a 
number and “plaque side”. 
124. The filters were placed on each plate with the writing side face down. The filters 
were marked asymmetrically with a needle dipped in India ink. After marking the 
filters, place the filters in the refrigerator for 5 min. This was repeated for a total of 
two filters for each plate. 
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125. The filters were carefully lifted off the plates to avoid disturbing the agarose overlay 
and placed plaque side up on sheets of Whatman 3MM paper saturated with a 
solution of .5 M NaOH, 1.5NaCL for 2 minutes with the plaque side-up. 
126. The filters were neutralized in the same manner by placing the filters plaque side up 
on 3MM paper saturated with .5 M Tris-HCl/ pH 7.5, 1.5 M NaCl for 5 min. 
127. The filters were placed plaque side up on Whatman 3 MM paper saturated with 2x 
SSC for 2 min. 
128. The filters were air dried for at least 15 minutes then UV crosslinked for a total 
energy exposure of 5,000 microJouLes/cm2. 
129. The filters were washed for 2-4 hours at 42°C (Shaking) in plaque wash buffer. 
130. Plaque wash buffer is 
50mM Tris pH 8.0 
1 M Nacl 
10 mm EDTA 
.1%SDS 
Pre-Hybridization of the Plaque Filters 
131. The filters were placed back to back in hybridizer tubes and 6mL of the Probe-Amp 
hybridization buffer was added for each pair of filters. 
132. Probe Amp hybridization buffer is 
5X SSC 
5.0 % (w/v) Dextran SuLfate 
0.5% (w/v) Blocking Agent 
0.1% (w/v) SDS 
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100ug/mL Denatured/Sheared Salmon Sperm DNA 
 
133. The prehybridizing filters were incubated for 1-6 hours at 60°C in a HB-1D 
hybridiser (Techne). Lower temperatures were also tried in following screens. These 
include 42°C , 50°C and 55°C. 
Hybridization of the Plaque Lift Filters 
134.   4uL of the labeled probe was added to 46uL of the Pro-Amp hybridization buffer. 
One tube was added for every pair of filters. 
135. The probe was heated at 95°C for 5 min to denature the probe and Spun briefly and 
placed on ice. 
136. The denatured probe was added to the hybridization tube and the filters were 
hybridized over night (up to 17 hrs) at 65C 
137. The filters were transferred to a container with 1X SSC, 0.1% SDS for 15 min. 
138. Then the filters were transferred to a second container with 0.5X SSC, 0.1% SDS 
and washed for 20 min at 65°C in a rocking incubator. 
139. The filters were rinsed briefly in ECL buffer 1 
140. The filters were transferred to a large container and incubated in blocking solution 
for 1 hour at room temperature with gentle rocking. Blocking solution was 0.5% 
nonfat dry milk in ECL buffer 1. 
141. The filters were rinsed briefly in ECL buffer 1. 
142. A pair of filter was placed in 50mL of Antibody Solution for 1 hour at room temp 
with rocking.  
143. Antibody solution is: 
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1:1000 dilution of anti-FL-HRP (Amersham) conjugate in a solution of 0.5% BSA 
in ECL buffer 2. 
144. The filters were washed in ECL buffer 2 with 0.1% Tween 20 at room temperature 
twice for 10 minutes followed by three additional washes for 5 min. The filters were 
left in the final wash solution until film exposure. 
145. In the dark : ECL detection solutions 1 and 2 were mixed to give sufficient volume 
to cover the filters .125mL/cm2. 
146. The filters were removed from the last wash solution and the excess fluid was 
blotted off on whatman filter with plaque lift side face up. 
147. The filters were placed in a clean container with the detection solution for 1 minute 
at room temperature. 
148. The excess detection buffer was drained and the filters were wrapped in saran wrap 
with care to smooth out the air bubbles  
149. The filters were placed plaque side up in a film cassette and a sheet of X-ray film 
(Amersham’s ECL X-ray film) was placed onto the blots. The film was exposed for 1 
minute. 
150. The film was removed and developed using a Kodak auto processor. A second sheet 
of film was then placed under the blots and exposed for 3 minutes. The film was then 
developed. 
151. The lumigrams were then aligned and marked with the unique marks of each plaque 
lift.  
152. The positive clones were then picked and replated with a repeat of the above 
screening protocol.  
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EST Putative Identification 
 Similarity searches were performed on the obtained sequences through NCBI’s 
BLAST search using the blastn search on the non-redundant database with the filter set to 
default. A match was considered significant if a similarity greater than or equal to 75% 
was returned for a continuous overlapping region of at least 70bp. Alignments of ESTs 
from the same gene were performed using the software package Gentools (Biotools Inc., 
Edmonton Canada). 
 Three hundred and thirteen sequences were submitted to Genbank’s dbEST 
database and currently are available on-line. 
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Appendix ii 
 
Genotypic Classes of EI affected American Saddlebred horses 
 
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 AHT24 197 197 1 3.4 
 AHT24 197 199 4 3.6 
 AHT24 199 199 3 1.0 
      
   TOTALS 8  
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB 38 107 109 0 0.4 
 ASB 38 107 111 0 0.3 
 ASB 38 107 115 0 1.0 
 ASB 38 109 111 1 0.5 
 ASB 38 109 113 1 0.1 
 ASB 38 109 115 0 1.7 
 ASB 38 109 117 1 0.1 
 ASB 38 111 111 1 0.2 
 ASB 38 111 113 0 0.1 
 ASB 38 111 115 0 1.3 
 ASB 38 113 113 2 0.0 
 ASB 38 113 115 0 0.3 
 ASB 38 113 117 1 0.0 
 ASB 38 115 115 0 2.3 
 ASB 38 117 117 2 0.0 
      
   TOTALS 9  
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB14 111 111 2 0.0 
 ASB14 111 119 3 0.0 
 ASB14 113 113 4 0.1 
 ASB14 113 119 0 0.2 
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 ASB14 113 121 0 0.7 
 ASB14 113 125 0 0.8 
 ASB14 115 115 0 0.0 
 ASB14 115 125 0 0.3 
 ASB14 119 119 0 0.1 
 ASB14 119 121 0 0.7 
 ASB14 121 121 0 1.0 
 ASB14 121 125 0 2.3 
 ASB14 125 125 0 1.3 
      
   TOTALS 9  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 AHT3 127 127 0 0.2 
 AHT3 127 137 0 0.5 
 AHT3 127 139 0 0.1 
 AHT3 127 141 0 0.9 
 AHT3 129 129 0 0.6 
 AHT3 129 137 0 0.8 
 AHT3 129 141 0 1.5 
 AHT3 133 137 0 0.1 
 AHT3 133 141 0 0.2 
 AHT3 135 139 0 0.0 
 AHT3 137 139 0 0.1 
 AHT3 137 141 0 0.9 
 AHT3 141 141 9 0.9 
      
   TOTALS 9  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HMS18  164 164 0 0.2 
 HMS18  164 166 0 1.6 
 HMS18  164 168 0 0.4 
 HMS18  166 166 0 3.4 
 HMS18  166 168 0 1.9 
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 HMS18  168 168 1 0.3 
 HMS18  168 170 0 0.0 
 HMS18  170 170 4 0.0 
 HMS18  170 172 1 0.0 
 HMS18  170 174 1 0.0 
 HMS18  172 172 1 0.0 
      
   TOTALS 8  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HTG15 132 142 1 1.1 
 HTG15 138 138 0 0.0 
 HTG15 140 142 0 0.8 
 HTG15 142 142 8 4.4 
 HTG15 142 146 0 1.4 
 HTG15 146 146 0 0.1 
      
   TOTALS 9  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HTG20 140 144 0 0.1 
 HTG20 142 146 0 0.2 
 HTG20 144 144 0 0.6 
 HTG20 144 146 2 2.4 
 HTG20 144 150 0 1.1 
 HTG20 144 156 1 0.2 
 HTG20 146 146 3 2.4 
 HTG20 146 150 2 2.3 
 HTG20 146 156 0 0.5 
 HTG20 150 150 1 0.5 
 HTG20 150 156 0 0.2 
 HTG20 156 156 2 0.0 
      
   TOTALS 11  
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SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 LEX25 150 154 0 0.7 
 LEX25 150 156 1 0.6 
 LEX25 152 154 0 0.4 
 LEX25 152 156 0 0.3 
 LEX25 154 154 0 1.9 
 LEX25 154 156 5 2.9 
 LEX25 156 156 3 1.1 
 LEX25 160 160 0 0.0 
 LEX25 164 164 0 0.0 
      
   TOTALS 9  
      
      
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 LEXO4 277 277 0 0.023 
 LEXO4 277 291 0 0.749 
 LEXO4 279 289 1 0.000 
 LEXO4 289 289 4 0.042 
 LEXO4 291 291 4 5.994 
 LEXO4 291 293 1 0.499 
 LEXO4 291 295 0 0.499 
 LEXO4 291 297 0 0.749 
 LEXO4 293 293 0 0.010 
      
   TOTALS 10  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 VHL20 85 95 2 0.0 
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 VHL20 89 89 1 0.5 
 VHL20 89 95 0 1.1 
 VHL20 89 97 0 1.4 
 VHL20 89 99 0 0.4 
 VHL20 89 105 0 0.2 
 VHL20 93 97 0 0.1 
 VHL20 93 103 1 0.0 
 VHL20 95 95 0 0.6 
 VHL20 95 97 1 1.5 
 VHL20 95 99 1 0.5 
 VHL20 97 97 1 0.9 
 VHL20 97 99 1 0.6 
 VHL20 97 107 1 0.1 
 VHL20 105 105 0 0.0 
      
   TOTALS 9  
      
      
      
      
      
SADDLEBRED AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB 17 90 94 1 0.0 
 ASB 17 94 106 0 0.0 
 ASB 17 94 116 1 0.1 
 ASB 17 96 108 0 0.1 
 ASB 17 96 110 1 0.1 
 ASB 17 96 114 1 0.1 
 ASB 17 96 116 0 0.1 
 ASB 17 98 112 0 0.0 
 ASB 17 100 102 0 0.0 
 ASB 17 100 108 1 0.1 
 ASB 17 100 110 0 0.2 
 ASB 17 100 114 0 0.2 
 ASB 17 100 116 1 0.3 
 ASB 17 100 118 0 0.0 
 ASB 17 104 106 1 0.0 
 ASB 17 104 108 0 0.1 
 ASB 17 104 116 0 0.2 
 ASB 17 106 106 0 0.0 
 ASB 17 106 110 1 0.2 
 ASB 17 106 114 0 0.2 
 ASB 17 106 116 1 0.3 
 ASB 17 108 110 0 0.4 
  
120 
 ASB 17 108 112 0 0.2 
 ASB 17 108 114 0 0.4 
 ASB 17 108 116 1 0.6 
 ASB 17 110 110 0 0.2 
 ASB 17 110 112 0 0.2 
 ASB 17 110 114 0 0.5 
 ASB 17 110 116 0 0.8 
 ASB 17 112 112 0 0.1 
 ASB 17 114 114 0 0.2 
 ASB 17 116 116 0 0.6 
      
   TOTALS 10  
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Genotypic Classes of EI affected Belgian Draft horses 
 
 
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 AHT24 179 179 2 0.0 
 AHT24 181 181 1 0.4 
 AHT24 181 201 0 0.9 
 AHT24 199 199 0 0.1 
 AHT24 199 201 0 0.6 
 AHT24 201 201 0 0.6 
      
   TOTALS 3  
      
      
      
 
 
 
     
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB 17 90 90 0 0.7 
 ASB 17 90 100 0 0.5 
 ASB 17 90 114 0 0.3 
 ASB 17 90 120 1 0.0 
 ASB 17 102 102 1 0.0 
 ASB 17 102 104 2 0.2 
 ASB 17 102 106 1 0.2 
 ASB 17 102 120 1 0.0 
 ASB 17 104 106 0 0.5 
 ASB 17 104 118 0 0.2 
 ASB 17 106 106 0 0.2 
 ASB 17 106 114 1 0.2 
      
   TOTALS 7  
      
      
 
 
 
 
     
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB 38 109 109 1 0.0 
  
122 
 ASB 38 109 111 2 0.2 
 ASB 38 109 113 1 0.0 
 ASB 38 109 115 0 0.3 
 ASB 38 111 111 0 0.3 
 ASB 38 111 115 0 1.1 
 ASB 38 115 117 0 0.5 
 ASB 38 115 119 0 0.5 
 ASB 38 117 117 1 0.1 
      
   TOTALS 5  
      
      
      
      
      
BELGIANS AFFECTEDS Affected  
 Microsat Allele 1 Allele2 Observed Expected 
 ASB14 111 119 0 0.1 
 ASB14 113 113 3 1.1 
 ASB14 113 121 2 0.0 
 ASB14 113 125 0 2.2 
 ASB14 121 125 1 0.0 
 ASB14 125 125 0 1.1 
      
      
      
      
      
      
   TOTALS 6  
      
BELGIANS AFFECTEDS   
 Microsat Allele 1 Allele2 Observed Expected 
 AHT3 127 127 0 0.2 
 AHT3 127 133 0 1.0 
 AHT3 129 135 2 0.0 
 AHT3 129 139 1 0.0 
 AHT3 131 133 0 1.0 
 AHT3 131 135 0 0.3 
 AHT3 133 133 0 1.1 
 AHT3 133 137 0 0.3 
 AHT3 135 135 2 0.1 
 AHT3 135 139 1 0.0 
      
   TOTALS 6  
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BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HMS18  168 168 6 5.3 
 HMS18  168 170 0 0.7 
      
   TOTALS 6  
      
      
      
      
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HTG15 132 142 1 1.5 
 HTG15 132 146 0 0.8 
 HTG15 142 142 4 1.5 
 HTG15 142 146 0 1.5 
 HTG15 144 144 1 0.0 
      
   TOTALS 6  
      
      
      
      
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 HTG20 144 144 2 0.4 
 HTG20 144 146 0 1.5 
 HTG20 144 148 0 0.4 
 HTG20 146 146 1 1.5 
 HTG20 146 148 1 0.8 
 HTG20 146 150 1 0.0 
 HTG20 146 156 0 0.8 
 HTG20 152 154 1 0.0 
      
   TOTALS 6  
      
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 LEX25 154 154 2 0.4 
 LEX25 154 156 0 0.2 
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 LEX25 154 158 0 1.1 
 LEX25 158 158 1 0.8 
 LEX25 158 160 0 1.4 
 LEX25 160 160 3 0.6 
      
   TOTALS 6  
      
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 LEXO4 275 275 0 0.8 
 LEXO4 277 289 0 1.6 
 LEXO4 279 295 1 0.0 
 LEXO4 285 285 2 0.0 
 LEXO4 289 289 1 0.8 
 LEXO4 291 295 1 0.0 
 LEXO4 293 293 1 0.0 
 LEXO4 295 295 1 0.0 
      
   TOTALS 7  
      
      
      
      
      
BELGIAN AFFECTEDS  Affecteds  
 Microsat Allele 1 Allele2 Observed Expected 
 VHL20 85 85 1 0.1 
 VHL20 85 97 0 0.4 
 VHL20 85 103 1 0.0 
 VHL20 87 105 0 0.1 
 VHL20 93 99 1 0.0 
 VHL20 95 99 0 0.1 
 VHL20 97 97 0 0.4 
 VHL20 97 103 1 0.0 
 VHL20 99 101 0 0.4 
 VHL20 99 103 2 0.0 
      
   TOTALS 6  
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